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Back ground:  
Globalization and industrialization has lead the shift workers vulnerable for 
circadian rhythm sleep disorders 
Aim & Objective:  
To know how far the sleep parameters secretory pattern of melatonin levels in 
saliva are deviated in shift workers from that of the day workers  
  
Materials &Method:  
The study included 30 age matched male shift workers (mean [SD] age: 21.33 
[0.48] years) and 30 healthy day workers (mean [SD] age: 24.97 [2.55] years). 
Polysomnography was performed along with self rated subjective sleep scoring 
questionnaires. Three Saliva samples for the measurement of melatonin were 
collected from participants resting in dim light at 2 hr min intervals between 20:00 
and 00:00 hr. 
Result 
Total sleep time, Sleep Efficiency, and duration of rapid-eye-movement sleep 
showed a significant reduction while Slow-wave sleep (stages 3+4) doesn’t show a 
significant reduction in shift workers as compared with day workers. A significant 
decrease in time line trend of salivary secretion of melatonin was observed in shift 
workers. Subjective sleep scores were significantly more towards inadequate sleep 
for shift workers. 
Conclusion: 
The circadian phase is altered in shift workers as compared to day workers proved 
using salivary melatonin concentration as a marker of the same. This study showed 
shift workers are more prone for sleep disorders, affecting one’s health and 
productivity in society. Early diagnosis, behavioral and life style modification, 
health education and medication, may alleviate such problems. 
Keywords: shift work, polysomnography, melatonin, circadian cycle 
STUDY OF PATTERN OF SECRETION OF 
MELATONIN IN SALIVA AND SLEEP PARAMETERS 
IN SHIFT WORKERS 
 
Introduction:  
 Until the mid 20th century, sleep was considered as a passive 
happening, dormant phase of everyday life. Common thought of sleep is 
that “it is a passive, inactive part of our daily lives”. Recent studies 
revealed that “during sleep our brains are very active”. In addition, sleep 
affects mental and physical wellbeing and hence our daily life in many 
ways that we are just beginning to recognize. 
Sleep is essential for survival and good wellbeing, but necessary of 
sleep and what sleep does to our wellbeing is not fully known. Sleeping 
hours for an individual may vary widely, usually from 6 to 10 hours a 
day. Nearly all people sleep at night. Yet, many individuals ought to sleep 
during the time of the day to become accustomed to working schedules—
a condition that is followed by sleep disorders. 
Hours of sleep against age 
 Children need more sleep per day in order to develop and function 
properly: up to 18 hours for newborn babies, with a declining rate as a 
child ages. REM sleep of a newborn is nearly 9 hours a day. After the age 
of five REM sleep component declines nearly more than two hours. 10 to 
11 hours of sleep is required for school children as evidenced by studies1. 
Age and condition Sleep Needs 
Newborns (0–2 months) 12 to 18 hours 
Infants (3–11 months) 14 to 15 hours 
Toddlers (1–3 years) 12 to 14 hours 
Preschoolers (3–5 years) 11 to 13 hours 
School-age children (5–10 years) 10 to 11 hours 
Adolescents (10–17 years) 8.5 to 9.25 hours 
Adults, including elderly 7 to 9 hours 
 
Emotional imbalance or excitement, age, food habits, and use of 
medications and aging are the factors known to decide the hours of one’s 
sleep and subsequently the feeling of refreshed after waking up. For 
instance, drugs can cause drowsiness as well as on the other hand make 
difficult to fall asleep. Caffeine, spicy ingredients, and monosodium 
glutamate (MSG), may interfere with onset of sleep. Aged people may 
fall asleep soon as well as they have least adjusting nature to the change 
of sleeping schedules. 
1.1 Physiology of Sleep:  
 This is widely divided into two following Phases of Sleep 
according to the multiple electrophysiological recording parameters as 
Rapid Eye Movement (REM) and Non-Rapid Eye Movement (NREM) 
1.2 Stages of Sleep Cycles: 
 The EEG pattern recorded during sleep varies in a cyclic fashion, 
which repeats in about every 90 minutes. There are about four cycles in 
normal 6 to 8 hours of sleep.  In normal individuals, sleep cycle begins 
with slow-wave sleep or Non-REM sleep. There are four stages of slow-
wave sleep: stages 1 to 4.  
 A person when falls asleep, passes sequentially through these four 
stages of increasingly deep sleep. After that, the sleep lightens and he 
enters into REM period. With completion of REM phase, sleep cycle 
completes. The REM phase is followed by the next new cycle, i.e. with 
stage 1 of non-REM sleep.  
 Thus, the cycle repeats in every 70 to 90 minutes. Throughout the 
night, people wake up briefly (called stage W) but are typically unaware 
of being awake. There are differences in the proportion of time spent in 
the various sleep stages in different age groups. Moreover, each 
individual has his or her own characteristic pattern. Usually, there is a 
predominance of deep slow wave sleep during the early part of the night, 
and the first REM sleep may occur after an hour.  
 REM stage becomes prevalent during the later part of the night. In 
general, REM sleep occupies about 25 per cent of total sleep period. The 
duration of REM sleep and stage 4 sleep decrease gradually with 
advancing age. Newborns and infants sleep about 18 hours a day of 
which 50% is spent in REM sleep. 
1.3 EEG Features of Sleep 
 In 1953, Aserinsky, Dement and Kleitman through EEG and 
polygraphic analysis described different phases of normal sleep 
characterized by EEG, autonomic and endocrine changes.  
During wakefulness, EEG usually shows desynchronized, high-
frequency, low amplitude known as beta waves in the range of 14 – 30 
Hz. 
During quiet rest with eyes closed, waves range from 8 to 12 Hz, 
i.e. alpha waves.  
 
 
1.4 Architecture 
Non-REM sleep: 
Stage 1 : Alpha rhythm is replaced by high frequency low  
amplitude EEG waves. 
Stage 2 :  Appearance of sleep spindles and K complexes. 
Stage 3 & 4 :  Delta waves (slow wave)  
(Commonly called as deep sleep) 
 - Delta waves in EEG reflect synchronized oscillations of 
thalamocortical circuit activity. 
REM sleep: 
 - High frequency, low amplitude activity with PGO spikes 
REM is characterized by rapid eye ball movement and profound 
atonia of other limb muscles (except for extraocular, inner ear and 
respiratory muscles). 
 Among these stage 2 sleep occupies50 percent of our total sleep 
time, REM sleep 20%, and the remaining 30 percent in the other stages. 
Infants sleep on the other hand, occupies 50% of their sleep time in REM 
sleep. 
 Recent evidences show that “theta oscillations during REM are 
driven by neurons in the proceruleus area in pons and atonia is caused 
neurons in the adjacent sublaterodorsal area. (Lu et al, 2006).These ‘REM 
on’ zones are inhibited by nearby ‘REM off’ area including ventrolateral 
PAG and lateral pontine tegmentum. ‘REM on’ area can also inhibit 
‘REM off’ area. Mutual inhibitions between these areas produce ‘flip-flop 
switch’ that ensures sharp and complete transition between REM and 
NREM sleep”. 
REM switch is influenced by: 
 - Cholinergic neurons that promote REM sleep 
 - Noradrenergic and serotonergic neurons that inhibit REM sleep. 
 
Figure 1 Stages of Sleep Cycle 
 NREM Sleep-changes in EEG and consciousness (which is 
primarily a cerebral function) are classified into four stages respective to 
increasing depth of consciousness. Depth of unconsciousness will 
become more for as sleep progresses from stage 1 to 4. EEG shows a 
progressively slower in frequency and higher-voltage pattern 
(furthermore called slow wave, delta wave) 
NREM-Thinking and Body Activities: 
Thinking in NREM is short, rudimentary and not able to recollect, 
Muscle tone is present, and Deep Tendon Reflex can be elicited. Chin and 
limb muscles exhibit EMG activities. 
NREM sleep-autonomic changes: 
 Widespread decrease in autonomic activities, hypotension and 
decreased heart rate, and decreased generalized cellular metabolism are 
noted. 
NREM sleep-Hormonal changes: 
 Growth Hormone, Cortisol and Prolactin secretion occurs mostly in 
NREM sleep. GH is secreted in 30 to 60 minutes after the beginning of 
sleep. 
 Biochemical changes like increased serotonin activity is noted in NREM 
sleep. 
Function of NREM sleep: 
 Main characteristics of NREM sleep are slow wave in EEG, 
decreased generalized metabolic activities and deep unconsciousness help 
revitalize the body  
Hence, early night time period is occupied by NREM or slow wave 
sleep predominantly, while late night phase is occupied by REM which is 
lighter and dream filled. 
EEG/EMG characteristics of REM sleep: 
 EEG is more active than NREM.  Low voltage fast with ocular 
movement artifact is noted in EEG. EMG is relatively reflecting atonia in 
REM sleep related to flaccid muscles. While other body activities are as 
active as like that of awake state. 
LATENCIES: 
 “Sleep latency is defined as the interval to fall asleep after retiring. 
Normal range is 10-20 minutes” 
 “REM latency is defined as once asleep, the interval from falling 
asleep to the first REM sleep is called REM latency”.  It may last for 90-
120 minutes within one cycle. Variations of above two latencies are 
useful in diagnosing many sleep disorders. Some disorders may affect 
one of the two latency and they are distinct to each other. 
1.5 Hormone of sleep - Melatonin 
 An endocrine hormone related to sleep which was thought to 
maintain biological clock in human being is melatonin. The pineal gland 
situated in the posterior end of epithalamus predominantly secretes 
melatonin. The melatonin signal form contribution of circadian cycle. Its 
biological activities include causing drowsiness. But the daily cycle is 
controlled by central nervous system by means of the endocrine and 
paracrine systems considerably than the melatonin signal alone. 
Melatonin (5-methoxy-N-acetyltryptamine,) 
 Melatonin is a hormone present in all living beings from algae to 
humans. Chemically it is N-acetyl-5-methoxytryptamine. It exhibits 
diurnal variation that varies with the time of the day. Melatonin act on 
melatonin receptors to exert its organic effects. Melatonin also protects 
nuclear and mitochondrial DNA thus exhibits its antioxidant property. 
Production 
 In higher animals, apart from pinealocytes in the pineal gland the 
retina, lens and GI tract are also tend to produce melatonin. Tryptophan 
an essential aminoacid forms the precursor for synthesis of melatonin by 
the enzyme 5-hydroxyindole-O-methyltransferase. Production of 
melatonin by the pineal gland is under the control of the suprachiasmatic 
nucleus (SCN) of the hypothalamus. Retina is the one that mediates 
information about the environmental light pattern daily. 
 A small group of inner retinal ganglion cells senses the light by 
special receptors and conveys light/dark information towards SCN. These 
cells represent 2% of retinal ganglion cells in humans and have the 
photopigment melanopsin not involved in vision. The sensitivity of 
melanopsin is with peak sensitivity at 484 nm (blue light). This 
photoperiod signal entrains the circadian rhythm, thereby subsequent 
neural and endocrine signals regulates behavioral and physiological 
circadian rhythms.  
Distribution 
 Melatonin produced and released into the blood like that as an 
endocrine hormone. While melatonin produced by the retina and the 
gastrointestinal (GI) tract functions like a paracrine hormone. 
Light dependence 
 
 
 ‘Production of melatonin by the pineal gland is inhibited by light 
and permitted by darkness as shown in above flow chart. It has been 
called "the hormone of darkness" and its onset each evening is called the 
Dim-Light Melatonin Onset (DLMO)’. Secretion of melatonin, and its 
level in the blood, peaks in the middle of the night, and gradually falls 
during the latter half of the night, with normal variations in timing 
according to an individual's daily life sleeping habits. 
 Until recent century, humans in temperate zones were exposed to 
up to 18 hours of darkness in the winter. In the current world, electricity 
reduces this to on average eight hours or less per day all year round. Low 
light levels can eb sufficient to inhibit melatonin production to some 
level. However bright light can reduce melatonin production to greater 
extent. 
 “Reduced melatonin production has been proposed as a likely 
factor in the significantly higher cancer rates in night workers, and the 
effect of modern lighting practice on endogenous melatonin has been 
proposed as a contributory factor to the larger overall incidence of some 
cancers” in the developed world as revealed by some studies. 
 
 
Antioxidant 
 Apart from its chief function as synchronizer of the biological 
circadian clock, anti-oxidant activity of melatonin is also a notable one. 
In many lower life forms, melatonin functions for only this purpose. 
‘Melatonin is able to cross cell membranes and the blood-brain barrier’. 
Contrasting to other antioxidants, redox cycling is not evidenced in 
melatonin. Redox cycling is the property of a compound to undergo 
reduction and oxidation repeatedly. 
 
Therefore, it has been referred to as a ‘terminal (or suicidal) antioxidant’. 
Immune system 
 While it is clear that melatonin interacts with the immune system, 
the details of those interactions are unclear. There have been few trials 
designed to judge the effectiveness of melatonin in disease treatment. 
Most existing data are based on small, incomplete, clinical trials. Any 
positive immunological effect is thought to result from melatonin acting 
on high affinity receptors (MT1 and MT2) expressed in 
immunocompetent cells. The increased immune system activity may 
aggravate autoimmune disorders. In rheumatoid arthritis patients, 
melatonin production has been found increased when compared to age-
matched healthy controls. 
Dreaming 
 Many supplemental melatonin users have reported an increase in 
the vividness or frequency of dreams. Extremely high doses of melatonin 
(50mg) dramatically increased REM sleep time and dream activity in 
both narcoleptics and those without narcolepsy. 
Melatonin level 
 Melatonin level in plasma is found to be in range from 30 to 250 
pg/ml according to the decreasing age. Melatonin level progressively 
declines as the age advances as shown in the table. This hormone also 
exhibit diurnal variation i.e. its level raises towards the end of the day. 
  
Figure 2  Plasma and Salivary Melatonin versus Time 
 Light inhibits the production of melatonin by the pineal gland and 
darkness favors its production. For this purpose melatonin has been called 
"the hormone of darkness" and its onset during evening is called the 
“Dim-Light Melatonin Onset” (DLMO). Dim light favors increased 
production of hormone. In early hours of the night the hormonal level 
raises maximum in blood. This is due to increased secretion in initial 
night hours and gradually falls during the next half of the night (fig: 2). 
this may vary in timing according to one’s chronotype. 
1.6 Physiologic Effects of Sleep: 
 Nervous system and other functional systems in the body are the 
two major aspects on which sleep exerts its physiological effects. The 
effects on nervous system are the more important because any person 
who has a transected spinal cord in the neck shows no harmful effects in 
the body beneath the level of transection that can be attributed directly to 
a sleep wakefulness cycle. Deprivation of sleep has an effect on the 
normal activity of the central nervous system.  
 Prolonged wakefulness is usually coupled with progressive 
malfunction of the thought processes and at times causes abnormal 
behavioral actions. We are all well-known with the increased 
sluggishness of thought that occurs after a extended awake period.  But as 
well, a person can become short-tempered or even psychotic after forced 
wakefulness. Thus, sleep in several ways brings back normal levels of 
brain activity and normal “balance” among the different functions of the 
central nervous system. Since overuse of some brain areas during 
wakefulness could easily throw these areas out of balance with the 
remainder of the nervous system. We might postulate that the principal 
value of sleep is to restore natural balances among the neuronal centers. 
The specific physiologic functions of sleep remain a mystery, and they 
are the subject of much research2 . 
1.7 Shift work and Sleep 
 With the dawn of publicly available electric light in the late part of 
19th century, mankind came out of the natural day–night (circadian) cycle. 
Economic and social requirements are now forcing the construction of a 
24-hour society coupled with both economic profit and possible risk of 
health. A study in the United States, reveals that “more than 15 million 
people (16.8%) of the full-time workers work on alternate shifts3(beers 
TM et al 2000)”, that is working hours are during periods other than 6 
AM to 6 PM. Major health troubles among shift workers include sleep 
disorders4 (Akerstedt T et al 1982), gastrointestinal disorder, increased 
incidence of cardiovascular disease, and possible increased incidence of 
type II diabetes mellitus5 (Rajaratnam SM,et al 2001). 
“Shift work is highly prevalent in mechanized societies. An 
alteration in the sleep wake cycle produced by the dislocation of sleep to 
the daytime and work to the night time will impede with the circadian and 
homeostatic control of sleep. American Academy of Sleep Medicine 
states that Shift-work sleep disorder consists of insomnia or excessive 
sleepiness that occurs as transitory phenomena related to work hours that 
are programmed during the usual sleep period. Shift work with deviant 
sleep schedule imposes a stress on the regular circadian rhythm and the 
exact margin between a normal response and a pathological response to 
this circadian stress remains unclear. 
Shift work sleep disorder (SWSD) is a type of circadian rhythm 
sleep disorder in which the endogenous circadian sleep wake cycle is 
normal and the disturbance arises from controversy between the pattern 
of sleep and wakefulness generated by the circadian system and the 
preferred pattern of sleep and wakefulness required by shift work.     
Long duration shifts greater than 12 hours and individual 
susceptibility for phase intolerance may lead to a diagnosis of shift work 
disorder i.e., those workers on shift time schedule with the greatest 
sleepiness and performance impairment during the biological night and 
insomnia during the biological day. Most of the medical disability due to 
shift work occurs in night or early morning shift workers. 
 A shift worker trying to sleep in the day time in general sleeps 1.5 
to 2 hours less than their night sleeping counterpart. They tend to miss out 
a major portion of REM sleep and the quantity of stage 2 sleep is not as 
much of a normal person. This results in "fragmented sleep." Less 
daytime sleep is a result of the altered sleep/wake cycle as well as 
concerned with external daytime sound stimuli such as calls, machineries 
and dogs. It has been revealed that noise stimuli, even if it does not wake 
one from sleep, has an impression on one's sleep cycles. 
 The night shift worker while working on nights have got to deal 
with sleep deprivation in addition to the effect of the trough of the 
circadian rhythm. Due to this it is difficult for a shift worker to keep from 
feeling tired. 
 The objective of this present study is to find the prevalence of Shift 
Work Sleep Disorder, distribution of their stages of sleep, detectable 
abnormalities in sleep study and their trough value, amplitude of pattern 
of melatonin secretion in saliva during onset of night hours, widely 
known as Dim Light Melatonin Onset in rotational shift workers and 
comparing the same parameters with age and sex matched day workers. 
 
 
REVIEW OF 
LITERATURE 
REVIEW OF LITERATURE 
2.1 .1 Regulation of sleep: 
 Different factors are involved in regulation of sleep. The main 
focus has been on the interaction between the homeostatic and the 
endogenous circadian processes6(Dijk DJ, et al 1995). The homeostatic 
process accumulates as a function of prior wakefulness, i.e., there is more 
homeostatic factor the longer you are awake7(Dijk DJ, et al1990).  If one 
is awake for long time, he will get the sleep deeper (increased slow wave 
activity). The circadian factor on the other hand plays an important role in 
sleep quantity; that is, sleep duration is for the most part determined by 
when you go to bed. In other words, sleep length is not dependent on the 
sleep homeostatic factor, but largely dependent on when you go to sleep 
according to your own circadian rhythm. 
 Night workers have experienced this as their sleep duration is 
usually shorter (often less than 6 h) than normal when going to bed in the 
morning, even though they often have been awake for more hours before 
going to bed than daytime workers8 (Akerstedt T. et al 2003). From a 
practical point of view, this interaction between the homeostatic and 
circadian processes means that it is important to be awake for a 
substantial amount of time to get sleep of high quality, and to have 
regular bed and rise times in order to have stable sleep duration.  
 Also habits and behavioral factors have large influences on sleep. 
We all go to bed at regular hours, not necessarily because we are very 
sleepy/ tired, but because we know we need to do so, to get enough sleep. 
Many people experience a high level of sleepiness early in the 
evening/afternoon, but avoid going to bed knowing that it is not time for 
bed yet. Behavioral factors can override both the homeostatic and 
circadian factors. For instance, a night worker is able to stay awake even 
though both the homeostatic and the circadian factors favor sleep in the 
middle of the night.  
 In these instances behavioral factors, like talking to someone, 
walking around, drinking coffee, increasing illumination, etc., help the 
night workers to stay awake. Similarly, many teachers have experienced 
students falling asleep at 9 a.m., even though both the homeostatic and 
circadian factors favor wakefulness. In this instance, lack of stimulation 
may be a behavioral factor explaining the increase in sleepiness and risk 
of falling asleep; that is, a boring lecture, sitting in a dark room, lack of 
sensory input, etc. 
  
2.1.2 Effect of sleep deprivation 
 A study done at Research Laboratory “Sports Performance 
Optimization” National Center of Medicine and Science in Sports 
(CNMSS), Tunis, Tun isia, evaluated the effect of partial sleep 
deprivation on the diurnal variations of cognitive performance of 
handball goalkeepers. 3 cognitive tasks by the use of the reaction time 
(RT), the stroop, and the barrage tests (to evaluate the RT, the selective 
and supported attention respectively) following 2 situations of sleep 
deprivation. The results showed an increased RT and a fall of the level of 
the attention after the partial sleep deprivation in the afternoon hours. It 
concluded that partial sleep deprivation affects the diurnal variation of 
cognitive performance by increasing the RT and reducing the attentional 
capacities in the afternoon hours9 (Mohamed Jarraya et al 2013). 
 “A survey of sleep deprivation patterns and their effects on 
cognitive functions of residents and interns in Korea revealed  severe 
sleep deprivation was associated with higher level of stress, more 
frequent attention deficit, and difficulty in learning (P < 0.05), but not 
with decreased neuropsychological test results (Hee Jin Kime et al)”. 
  
2.1.3 Sleep and memory consolidation: 
 There is now a large body of literature supporting the notion that 
sleep plays a major role in memory consolidation. The most prominent 
theory regarding the mechanism is that recently acquired representations 
are preferentially reactivated during sleep. In the context of declarative 
memories, this involves reactivations of memories in the MTLs during 
slow wave sleep1011( Peigneux, P., et al. 2004 ; Wilson, M. A., & 
McNaughton, B. L. 1994), which strengthen and stabilize the memories, 
making them more resistant to interference12( Diekelmann, S., et al2011) 
and more likely to be retained1314( Rasch, B., et al. 2007; Rudoy, J. D., et 
al 2009). 
2.1.4 Sleep - necessary for survival: 
 Even though we don’t know exactly why sleep is needed by 
people, there are evidences of animal studies that have proved the 
necessity of sleep for survival. For example, life time of rat is normally 
two to three years. But the survival time of rat becomes lesser for the 
REM deprived rats as 5 weeks and as 3 weeks for the rats which are 
deprived of all stages of sleep. Body temperatures fell abnormally low 
and sores were noticed on their tail and paws in rats deprived of sleep. 
The etiology of sores was found to be compromise in rats' immune 
system. 
 Normal functioning of nervous system requires proper sleep. This 
is obvious in our day to day life, where in sleep deprivation for one day 
may lead to drowsiness and impaired concentration in memory and deter 
our physical performance. Hallucinations and mood swings have been 
reported in prolonged sleep deprivation. Sleep deprivation may lead to 
break down of neurons due to depletion of energy and accumulation of 
metabolites of normal cellular activities. Sleep also may give the brain a 
chance to exercise .Important neuronal connections which are required 
for prevention of damage from lack of activity and sleep helps in this 
process. 
 Deep sleep coincides with the release of growth hormone in 
children and young adults. Many of the body's cells also show increased 
production and reduced breakdown of proteins during deep sleep. Since 
proteins are the building blocks needed for cell growth and for repair of 
damage from factors like stress and ultraviolet rays, deep sleep may truly 
be "beauty sleep." Activity in parts of the brain that control emotions, 
decision-making processes, and social interactions is drastically reduced 
during deep sleep, suggesting that this type of sleep may help people 
maintain optimal emotional and social functioning while they are awake. 
A study in rats also showed that certain nerve-signaling patterns which 
the rats generated during the day were repeated during deep sleep. This 
pattern repetition may help encode memories and improve learning. 
2.1.5 Sleep disorders 
 A sleep disorder is a physical and psychological condition or 
disturbance of sleep and wakefulness caused by abnormalities that occur 
during sleep or by abnormalities of specific sleep mechanisms. Although 
the sleep disorder exists during sleep, recognizable symptoms manifest 
themselves during the day. Accurate diagnosis requires a 
polysomnogram, widely known as a "sleep test”. 
 Sleep disorders involve disturbances in the ability to fall asleep, 
stay asleep, or stay awake or unusual behaviors during sleep, such as 
sleepwalking. Sleep can be disturbed by many factors, including irregular 
bedtimes, activities before bed, stress, diet, disorders, and drugs. 
 The most common symptoms of sleep disorders are insomnia and 
excessive sleepiness during the day. People with insomnia have difficulty 
falling and staying asleep and wake up feeling unrefreshed. Lack of sleep 
makes people feel sleepy, tired, and irritable during the day. People with 
excessive daytime sleepiness tend to fall asleep during normal waking 
hours. Some sleep disorders make people unable to resist falling asleep 
during the day. 
 Some sleep disorders involve involuntary movements of the limbs 
or other unusual behaviors (such as nightmares, night terrors, or 
sleepwalking) during sleep. Other symptoms may include problems with 
memory, coordination, and emotions. People may perform less well in 
school or at their jobs. The risk of having a motor vehicle accident or 
developing a heart disorder is increased. A detailed description of the 
problem, sometimes with information from a sleep log, usually indicates 
the diagnosis, but sometimes testing in a sleep laboratory is needed”. This 
testing includes polysomnography. 
2.2 Shift work: 
 The term “shift work” refers to regular employment outside of the 
normal “day work” hours. “Human beings are diurnal creatures for whom 
it is biologically unnatural to work at night, thus leading to the potential 
for impairments in work alertness and interference with day time sleep. 
Society expects evenings and weekends to be free for social, religious and 
recreational activities, thus placing shift workers at a disadvantage, when 
they are required to be at work during evenings, overnight, or on 
weekends. 
 Approximately one fifth of all employees are engaged in some 
form of work that requires their presence outside of the “standard” 7am to 
6pm working day on a regular basis, and can thus be regarded as “shift 
workers”. “This figure is expected to rise to rise as second jobbing and 
mandatory overtime increase 15(U.S.Congress, office of technology 
Assessment: Biological Rhythms: Implications for the Worker (OTA-
BA-463). Washington, DC, U.S. Government printing office.1991).  
 The fastest –growing sector of most western economies is the 
service sector, and people are increasingly demanding and receiving 
around the clock availability of such services. This leads to extended 
works week and fewer different work teams covering each 24-hour day. 
Physicians are thus increasingly confronted with patients whose 
conditions may be exacerbated by a failure to cope with the repeated 
changes in schedule that shift work requires. Some people cope well with 
shift work, others poorly. At the extreme , moore-ede16( Moore-Ede MC 
et al 1986) and others have referred to a shift work maladaptation 
syndrome in those failing to cope. The international classification of sleep 
disorders 17(ICSD 1990) formally lists shift work sleep disorder as one of 
the circadian rhythm sleep disorders. The diagnostic and statistical 
manual of mental disorders 18(American psychiatric association; 1994) 
lists shift work type as a subtype of circadian rhythm sleep disorder. 
        Although listed within circadian rhythm-related sleep disorders, shift 
work intolerance is a problem that should not be regarded as solely a 
circadian rhythm (biological clock) issue, or asleep disorder issue, or a 
social and domestic issue19(Knauth P, et al 2003).  Rather, it is a complex 
interaction of these three factors, with each factor influencing both of the 
other factors and the final outcome of shift work tolerance 20 (Monk TH: 
et al 1998). 
 
 
 Figure 3 Circadian Rhythm coping ability- Triple Factors 
  
2.2.1 CIRCADIAN FACTORS 
 “Unfortunately, it is quite clear that, like it or not, HOMO 
SAPIENS are a diurnal species, biologically hard-wired to be active 
during the day and sleepy at night. Working at night must therefore be 
regarded as an inherently unnatural act. 
 The prime negative influence of the circadian system stems from 
its inability to adjust instantaneously to the changes in routine that shift 
work schedules require 2122 (Aschoff J, Hoffmn K, pohl H, et al: 1975; 
Roach GF, Burgess H, Lamond N, et al: 2001 ). Figure illustrates the 
process of circadian system realignment (as measured by the phase of the 
circadian temperature rhythm) in two young volunteers who worked 21 
consecutive night shifts23 (Monk TH, Knauth P, folkard D, et al: 1978). 
 Thus 5 or 6 days were needed before the melatonin onset achieved 
its desired timing, just prior to the (day) sleep episode. In most work 
situations, however, this would bring the individual to an off-duty break 
when a reversion to a diurnal pattern would likely ensue. 
 As with other investigations, however 24(Czeisler CA, et al: 1990), 
these studies indicated that darkness during the sleep period was an 
important as the light during the awake period. Thus, complete bedroom 
light proofing was required, and (more problematically), Eastman and 
colleagues25 (Eastman CI et al 1994) showed convincingly that dark 
sunglasses or welder's goggles usually needed to be worn during the 
morning commute home from night work for the required circadian 
system phase delay to be accomplished, a procedure that might 
sometimes compromise traffic safety. 
 Another way of enhancing circadian adjustment is by taking 
melatonin pills - a strategy used by many night workers following the 
attention given to that hormone in the popular press. Whereas there is 
some laboratory evidence for the effectiveness of melatonin as a 
chronobiotic26 (Sack RL, et al 1997), its effects are comparatively weak 
compared to those of daylight and are likely to be washed out for many 
shift workers. Slightly different is the concept of using melatonin pills to 
facilitate daytime sleep (without necessarily changing the timing of the 
circadian pacemaker). However, although there is good laboratory 
evidence for such facilitation, double-blind studies of melatonin's effects 
in actual shift workers have resulted in few definitive improvements in 
the quality or duration of daytime sleep2728( Jorgensen KM et al 1998; 
James M  et al 1998). 
 In Europe, many companies are switching to rapidly rotating 
systems in which only one or two shifts are worked at a time, before a 
different one is worked29 (Knauth P, et al 1980). Thus, for example, on 
the continental rotation, employees work two morning shifts, two evening 
shifts, and two night shifts, followed by two days off. Most European 
experts favour such systems because they allow the circadian to retain its 
diurnal orientation, thus eliminating problems of desynchronosis. 
Because only one or two night shifts are worked before time off is given, 
sleep loss and fatigue are minimized. The drawbacks of rapid rotation are 
the circadian-related fatigue experienced during the night shifts”. 
  
 2.2.2 SLEEP FACTORS 
 “Sleep is the major preoccupation of most shift workers. In both 
Europe30 (Knauth P et al 1980) and the United states31 (Tasto DL et al 
1978), surveys have indicated that night workers get about 10 hours less 
sleep per week than their day-working counterparts. Thus, People who 
happen to need 9 hours of sleep per 24 hours in order to feel well rested 
very often find shift work extremely difficult to cope with. In his survey 
of field and laboratory shift work sleep studies, Akerstedt3233(Akerstedt T 
et al 1985; Akerstedt T et al 2005) concluded that the shortening in a 
night worker's day sleep comes primarily from a reduction in stage 2 and 
rapid eye movement (REM) sleep, with slow wave sleep relatively 
unaffected. Not surprisingly, given the prolonged levels of partial sleep 
deprivation involved, sleep latency can be somewhat reduced in night 
workers, and some studies have found shorter REM latencies to occur. 
Essentially, the problem is usually one of sleep-maintenance insomnia 
rather than sleep onset insomnia. 
 In this closely protected environment, there was a highly 
significant difference in duration between the day sleep of night workers 
and the night sleep of day workers (306 minutes versus 401 minutes, 
respectively). In addition there were reliable differences between the 
polysomnographic characteristics of the sleep, with a smaller amount of 
REM sleep and a greater proportion of slow wave sleep for the night 
workers. Thus, even if it were economically feasible, the complete 
soundproofing and light proofing all shift workers bedrooms would not 
eradicate the problem of sleep for shift workers. 
 Unless the shift worker is in a well-adjusted household, his or 
(more especially) her sleep is liable to be truncated by the demands of 
childcare, shopping and household management. In viewing the sleep of 
shift workers, one must therefore consider both endogenous and 
exogenous factors that are going to limit sleep time. 
 The use of hypnotics as done in a study of rotating shift workers, 
Walsh and colleagues34 (Walsh JK et al 1984) found that 0.5mg triazolam 
could improve the quality and duration of day sleep. However the study 
was also important in demonstrating that the drug had no significant 
phase-resetting effects”. 
2.2.3 Domestic factors 
 Certainly, if a shift worker’s domestic and social life is 
unsatisfactory, then the individual will not be coping satisfactorily, 
however well adjusted the sleep and circadian rhythm may be. The 
additional tasks falls on the female shift worker are child care and 
household management. Another aspect of domestic disruption concerns 
the role of the male shift worker as husband and parent. The factor may 
increase the risk of divorce by 57%35 (White L et al 1990) in a 
longitudinal follow up study. Shift worker often suffers from social 
isolation from day working friends and from religious community 
organizations. 
2.2.4 Coping strategies: 
 “Employee education programs should emphasize the way 
circadian, sleep and domestic factors can influence the shift work coping 
ability. Workers should be taught good sleep hygiene practice and 
advised how they can manipulate zeitgebers to their advantage, enhancing 
those that are acting in their favour and attenuating those acting against 
them. They should also be taught the benefit of prophylactic naps. In 
some cases family counseling may be indicated to discuss solutions to 
some of the social and domestic problems. The creation of self help 
networks can often be of benefit, lessening some of the social and 
community isolation that many shift workers feel. When educational 
strategies fail and shift schedule cannot be changed, the patient may 
require to a day working job.  
 Management education include convincing the managers first for 
realizing the potential of problem, and making the wide range of different 
shift systems that are available, including the rapidly rotating systems so 
popular in Europe.  Recognition of factors such as type of job, nature of 
workforce, average commuting time, male female ratio, and 
preponderance of moonlighting that should influence the selection of 
optimal schedule for that work group in that situation. 
 Although some people cope well with shift work, many others have 
significant problems that can adversely affect their health and well being. 
These problems can become a shift work sleep disorder, which can be 
quite debilitating to the patient. Shift work problems can be usually 
understood with a multifactored approach that recognizes the interaction 
of circadian rhythms, sleep and social and domestic factors in 
determining shift work coping ability”. 
2.2.5 Alertness Strategies: 
 A variety of strategies have been empirically studied and shown to 
increase alertness in performance. These strategies include planned naps, 
caffeine, good sleep habits, managing the sleep environment, exercise, 
light and dark exposure, activity breaks, diet, sedative, hypnotic and 
stimulant medication and sleep scheduling363738( Howard SK et al 
2002; Rosekind MR et al 2002; Rosekind MR et al 1999 ). 
Scheduling: 
An individual worker can seek every opportunity to increase work hours 
and income, and an organization or corporation can limit these 
opportunities in order to reduce potential health and safety risks. 
Healthy Sleep: 
It is critical that individuals learn about potential sleep disorders that may 
affect them and seek help from accredited sleep medicine professionals to 
identify and treat underlying cause of sleepiness. 
Conclusion – Managing work schedules: 
 “Modern work schedules have evolved dramatically from their 
roots as traditional shift work to meet historical manufacturing and line 
operations. Effective clinical interventions may involve actions focused 
on each of these areas for optimal outcomes. 
Shift work sleep disorder is otherwise known as circadian rhythm sleep 
disorder. Its diagnostic criteria are published in the international 
classification of sleep disorders Revised (ICSD-2). 
Delayed sleep phase type (DSPT) and advanced sleep phase type (ASPT) 
are the two types of circadian rhythm sleep disorder and the former is the 
most commonly encountered in clinical practice”. 
Clinical Feature – DSPT: 
 “It is characterized by sleep onset and wake times that are usually 
delayed 3 to 6 hours relative to conventional sleep wake times (see 
figure). 
 
Figure 4 schematic representation of the temporal distribution of sleep 
and wake in patients with circadian rhythm sleep disorder 
Patient typically finds it difficult to initial sleep before sometime between 
2 and 6am and when free of social constraints prefers a wake time that is 
between 10am to 1pm3940 (Weitzman E et al 1979; Weitzman ED et al 
1981). The clinical picture may be similar to sleep onset insomnia. 
Enforced conventional wake times may result in chronically insufficient 
sleep and excessive day time sleepiness. In adolescent the syndrome may 
be associated with day time irritability and poor school performance 
where as in adulthood the symptoms are impaired job performance41 
(Thorpy MJ et al 1988) and associated financial difficulty as well as 
marital problems42 (Alvarez B et al 1992). 
Although actual prevalence in general population is unknown it is more 
common in adolescent and young adults with a reported prevalence of 
7%43(Pelayo R et al 1988).In middle aged adults the prevalence may be 
nearly 0.7%44(Ando K et al 1995). In sleep disorder clinics, 
6.7%45(Weitzman ED et al 1981) to 16%46 (Regestein QR et al 1995) 
patients with primary complaint of insomnia were determined to have 
DSPT.”  
2.2.6 Etiopathogenesis: 
 The tendency for late sleeping is not simply a function of 
interaction between circadian drive for wakefulness and sleep homeostat 
but is analogous to other physiological behaviors but overlaid by varying 
individual emotional social and medical states47( Regestein QR et al 
1995). “Late wake times will delay exposure to light in the morning and 
may prevent active advancement of the circadian clock allowing it to drift 
to a new phase relation with the external clock time. There is also 
evidence for genetic basis to DSPT. In some cases it is familiar with 
autosomal dominant mode of inheritance4849(Alvarez B et al 1992; 
Ancoli-israel S et al 2001). Polymorphisms in circadian gene such as 
hPer3, arylalkylamine N-accetyltransferase gene, HLA genes and 
Clock50515253 (Archer SN et al 2003; Hohjoh H et al 2003; Iwase T et al 
2002; Takahashi Y et al 2000)support the genetic basis”. 
2.2.7 Diagnosis: 
 The diagnosis of DSPT is usually made on the basis of the patient’s 
history of chronic or recurrent complaints of symptoms of insomnia 
resulting from a stable delay in the timing of the major sleep and wake 
periods5455(American academy of sleep medicine,2005; American 
psychiatric association 2000). Sleep log or actigraphy monitoring should 
be performed for at least 7 days to demonstrate a stable delay in the 
timing of the habitual sleep period. A morningness-eveningness scale, 
such as provided by the Horne-Ostberg questionnaire, is also useful to 
gauge the patients best time of performance. To make the diagnosis, 
medical, mental or sleep disorders that may cause alterations in the sleep-
wake cycle, insomnia or excessive sleepiness should be excluded or 
adequately treated. Nocturnal polysomnography is sometimes necessary 
to exclude other sleep-disrupting pathology. When performed during 
conventional sleep laboratory hours, PSG often shows prolonged sleep 
onset latency as well as prolonged rapid eye movement sleep latency, and 
this many times, in conjunction with an antecedent sleep log, be a clue to 
the diagnosis. 
 The use of other physiologic markers of circadian timing, such as a 
continuous recording of body temperature56 (Czeisker CA et al 1980) or 
dim light (plasma) melatonin onset (DLMO) 57(Shibui K et al 1999), may 
also aid in determining the phase relationship between circadian and 
terrestrial time, although routine clinical availability remains limited. 
DLMO is probably the most useful marker for circadian pacemaker 
output5859(Lewy AJ et al 1989; Lewy AJ et al 1999). In individuals with 
DSPT, the DLMO times usually occur after 10PM60 (Shibui K et al 
1999)(See figure). Determination of DLMO can be made by 
measurements of melatonin from plasma or saliva. Commercially 
available salivary determination of DLMO for clinical use may be 
feasible in near future. 
 Figure 5 Dim light profiles of individual with Advanced Sleep Phase 
Type DLMO at 7 pm (top); Delayed Sleep Phase Type with DLMO at 
1.30 pm (Bottom) the arrows indicate that the DLMO calculated as 
two standard deviation above the baselines 
 
2.2.8 Treatment: 
 The use of chronotheraphy has been successful in small group of 
patients in laboratory setting61(Czeisler CA et al 1981). Chronotheraphy 
requires a successive delay of sleep times by 3 hours daily over a 5 to 6 
day period until a desired sleep time is achieved.  
 This shift is followed by rigid adherence to a set sleep-wake 
schedule and good sleep hygiene practice. Therapy with bright light in the 
morning should advance the phase of circadian rhythms in DSPT and 
may be more practical than chronotherapy6263(Lewy AJ et al 1985;Lewy 
AJ et al 1985). Clinical application of bright light therapy remains 
empiric and there are no standard criteria for its use in DSPT. 
 Administration of exogenous melatonin also shifts the phase of 
endogenous circadian clock. It should be noted that the Phase Response 
Curve (PRC) for melatonin is nearly opposite to the PRC for light 
exposure. Melatonin delays circadian rhythms when administered in the 
morning and advances them when administered in the afternoon or early 
evening64(Lewy AJ et al 1992s). The relatively small number of clinical 
studies and variability in dose and time of administration have been 
limiting factors in the development of a standardized approach for 
treatment with melatonin. The combination of morning bright light and 
early evening melatonin may be even more efficacious in creating a phase 
advance, although clinical data are lacking. In summary the clinical 
approach to a patient with DSPT should initially include assessment of 
circadian sleep phase by sleep diary or actigraphy measures for a period 
of at least 7 days. Behavioral interventions such as a structured sleep 
wake schedule, good sleep hygiene practices and avoidance of exposure 
to bright light in the evening should be prescribed for all patients. In 
addition exposure to bright light in the morning (1 to 2 hours shortly after 
awakening) or administration of melatonin in the evening (5 to 6 hours 
before habitual sleep time) can advance the timing of the sleep wake 
cycle, although melatonin has not been approved for this indication. 
2.2.9 Shift work- a health risk: 
 Shift work, and night work in particular, is associated with 
negative effects, such as shortened and disturbed sleep, fatigue, decreased 
alertness, cognitive decrements, increased injuries and accidents, 
reproductive problems and risks to cardiovascular and gastrointestinal 
disease6566 (Akerstedt T et al 1990; Boivin DB et al 2007). These 
symptoms are experienced because shift workers rarely shift their 
endogenous circadian rhythms to align with the sleep wake schedule 
demanded by their occupations”. Night workers are therefore often in a 
constant state of circadian misalignment, and both work and sleep at the 
‘‘wrong’’ circadian phase. The symptoms due to circadian misalignment 
can be reduced even if the optimal phase relationship is not completely 
established. The magnitude of phase shift is positively related to the 
extent of improved performance and alertness during the night, and better 
daytime sleep at home(Burgess HJ et al 2002)67. 
 In 2001, two studies were published suggesting that disruption of 
the day–night cycle by exposure to light-at-night, especially through 
nighttime shift work, may be associated with increased incidence of 
breast cancer (Davis S et al 2001; Schernhammer ES et al 2004)6869.  
Davis et al70 reported on a case– control study among women who worked 
the night or “graveyard” shift, showing a greater risk of breast cancer 
associated with greater frequency and longer duration of night shift work. 
Graveyard shift work was associated with an odds ratio of 1.6 (95% 
confidence interval _ 1.0– 2.5). In the Nurses’ Health Study cohort, 
Schernhammer et al 71 examined 2441 incident breast-cancer cases and 
reported a trend of increasing breast cancer risk with increasing duration 
on the night shift. They conclude that women who work on rotating night 
shifts with at least three nights per month have a moderately increased 
risk of breast cancer after extended periods of rotating shift work. A third 
study on shift work and risk of breast cancer reported increasing risk by 
increasing duration of night work (Hansen J et al 2001)72. 
 “A 2003 study suggested an association between shift work and 
risk of colorectal cancer (Schernhammer ES et al 2003)73. Exposure to 
light at- night may increase risk of cancer by suppressing endogenous 
production of the neurohormone melatonin (Schernhammer ES et al 
2004; Stevens RG et al 2005; Schernhammer E et al 2004)747576 which has 
been observed to have potentially beneficial oncostatic, antioxidant, 
antiadduct, anti estrogenic, and immune modulation activities (Brzezinski 
A et al 1997; Reiter RJ et al 2004)7778. The antiestrogenic activities of 
melatonin are highly relevant to breast cancer risk and include 
interference with the estrogen receptor, reduction of estrogen production, 
and reduction of circulating estrogen79(Sanchez-Barcelo EJ et al 2005)”.  
 The primary function of melatonin is to convey information on 
night length to physiologic systems to organize circadian functions such 
as core body temperature 8081(Claustrat B et al 2005; Scheer FA et al 
2005) as well as seasonal physiology in other mammalian species82 
(Arendt J et al 2003).  Serum and saliva melatonin levels are normally 
very low during the day and the levels rise after dark, peaking in the 
middle of the night. Exposure to light during the dark cycle inhibits 
melatonin secretion in a dose-dependent manner, with a threshold of 200–
400 lux (lumens per square meter) and maximum inhibition after 600 lux 
for 1 h, 11 as well as being wavelength-sensitive, with maximum effect at 
approximately 446–477 nm8384(Lockley SW et al 2003; Brainard GC et al 
2001). 
 Future analytic studies of light-at night and cancer would benefit 
from surrogate measures to estimate lifetime exposure. Occupation, in 
particular shift work, may be correlated with important patterns of light 
exposure, but few direct measurements of light exposure in the workplace 
have yet been published8586(Koller M et al 1994; Dumont M et al 2001), 
and none have reported measurements for periods longer than 56 hours 
outside the laboratory. Longer measurement periods would allow 
comparison of rest days with workdays on different shifts or rotation 
patterns. 
 The high subjective self rated sleep scores during waking and 
working hours are consistent with reported fatigue and lack of alertness in 
shift workers, a major concern in occupational health and safety as with 
the study done by Borges FN  et al 2003 and Mistlberger RE  et al 
20038788( Borges FN et al 2003; Mistlberger RE et al 2004). 
 Measurement of melatonin has been performed primarily in the 
laboratory as well, using multiple samples of serum, or an overnight urine 
sample, although one study used salivary melatonin samples (5 per day) 1 
or 2 days per week over a period of 4 weeks89(Lowden A et al 2004). 
Serum and urine sampling methods have drawbacks, which our three-
sample saliva protocol avoided, including the logistics of drawing 
multiple blood samples, and the lack of information on 24-hour variation 
available from an overnight urine sample. Research into light-at-night as 
a cancer risk factor is at a very early stage and measurement is a critical 
area. This study addressed the feasibility and acceptability of 24-hour 
exposure measurement for an extended time period to include both 
workdays and days off in natural residential and occupational settings, 
and looked at whether years of shift work can be used as a surrogate for 
exposure to light-at-night. 
 A study conducted in telecom female workers in New Delhi on 
various shifts revealed that in case of the rotating shift, the increased 
demand in the perceptual and motor and the motivational aspects of work 
caused greater negative influence on physical health symptoms, and 
social and domestic disruption. The somatic anxiety was greater among 
women in night work. Findings of the multiple aspects of supported that 
the behavioral response to the work stressors, and health and well being 
dimensions did vary with shift schedules. The job design interventions 
tailoring to the type of work and work place ergonomics might improve 
the work stressors. The overlapping schedules of the rotating shift, 
including night work are the documented risk factors. Delayed morning 
shift for the operators in the rotating shift and adjustment of shift length 
based on the work and climatic load (e.g : reduced work hours in the 
evening shift to avoid peak workload, extend work hours in the day shift 
during the extremely hot summer months) might alleviate work stresses 
and enhance health and well being90(A.Nag et al 2004). 
2.3.1 Marker of circadian rhythm - Melatonin 
 For the treatment of Circadian rhythm sleep disorders, an 
understanding of the circadian timing system is of crucial importance. 
Sleep usually takes place when the melatonin level is high, and 
wakefulness normally coexists with low plasma melatonin levels. Based 
on the close correspondence between sleep/wakefulness and body 
temperature/melatonin, the core body temperature and melatonin 
(measured in saliva, urine or plasma) constitute the two most common 
physiological measures of circadian rhythm919293( Sack RL et al 2007; 
Brown EN et al 1992; Lewy AJ et al 1998). 
 The main site of this endogenous rhythm has been located in the 
Suprachiasmatic Nuclei situated bilaterally above the optic chiasma in the 
anterior basal hypothalamus94(Gillette MU et al 1999). Ablation of the 
Suprachiasmatic Nuclei in mammals has been shown to eliminate 
circadian rhythms, and transplantation restores the rhythm to the period 
of the donor animal95 (Ralph MR et al 1990). There exist several major 
input fiber systems in the Suprachiasmatic Nuclei. The most important 
stems from photo receptors in the retina, which covey signals to the 
suprachiasmatic nucleus via a monosynaptic pathway, the retino 
hypothalamic tract. Recently it was discovered that the retinal rod and 
cone cells are not required for photoentraiment, but that there exists a 
subset of retinal cells (2500 of a total of 100000 cells) containing a light 
sensing pigment, melanopsin, which is assumed to be involved in 
circadian photo entrainment96 (Hattar S et al 2002). Measurement of the 
circadian rhythm based upon the melatonin comprises several samples 
(normally with a 30 or 60 min interval) of saliva, urine or plasma. The 
level of illumination currently recommended for sampling is 10 
lux97(Pandi-Perumal SR et al 2007). The most commonly used parameter 
from these measures is the dim light melatonin onset (DLMO), normally 
defined as the time when the melatonin level reaches 2pg/ml in plasma 
98(Lewy AJ et al 1999) or when a level of 4pg/ml is reached in 
saliva99(Nagtegaal JE et al 1998)”. 
2.3.2 Treatment with exogenous melatonin  
 “Exogenously administered melatonin has phase shifting 
properties, and the effect follows a phase response curve (PRC) that is 
about 12hour out of phase with the PRC of light 100101102(Sack RL et al 
2007 Lewy AJ et al 1998; Arnedt J et al 2005). Melatonin administered 
in the afternoon or early evening will phase delay the circadian rhythm, 
whereas melatonin administered in the morning will phase delay the 
circadian rhythm. The magnitude of phase shifts is time dependent and 
the maximal phase result when melatonin is scheduled around dusk or 
drawn 103(Arnedt J et al 2005). 
 The effect of exogenous melatonin is minimal when administered 
during the night, at least during the first half of the night104 (Lewy AJ et al 
1996). Furthermore, similar to the effects of bright light, melatonin 
administered at an inappropriate time can actually worsen the Patient's 
condition. Melatonin has in addition to phase shifting properties, 
soporific effects. This is seen especially when taking melatonin 
medication during the daytime, when endogenous melatonin is low 
105(Arnedt J et al 2005). This effect may account for some of its benefit in 
the treatment of jetlag and shift work disorder. 
 There is no consensus regarding the appropriate dose or 
formulation of melatonin. Most studies use fast-release melatonin, but 
sustained-release preparations are commercially available. The doses 
used in most studies range from 0.5 to 5mg. Several studies show that the 
effects of melatonin are not clearly dose-related 106(Sack RL et al 2007), 
and the phase shifting effect is considered less than those associated with 
light exposure”. 
Treatment of circadian rhythm disorders 
Exogenous melatonin, usually taken orally in the afternoon or evening, is, 
together with light therapy upon awakening, the standard treatment for 
delayed sleep phase syndrome and non-24-hour sleep-wake syndrome.  
2.3.3 Studies related to SWSD and melatonin 
 In a Double-blind placebo-controlled study conducted in Private 
Suite of a general clinical research center where oral melatonin (0.3 mg 
or 5.0 mg) was administered 30 minutes prior to each 6.67-hour sleep 
episode. Both doses of melatonin improved polysomnographically 
determined sleep efficiency from 77% in the placebo group to 83% for 
sleep episodes occurring during circadian phases when endogenous 
melatonin was absent. However, this remained below the average sleep 
efficiency of 88% observed during sleep episodes scheduled during the 
circadian night, when endogenous melatonin was present. Melatonin did 
not significantly affect sleep initiation or core body temperature. 
Melatonin appeared to maintain efficacy across the study and did not 
significantly affect percentages of slow-wave sleep or rapid eye 
movement sleep (Wyatt JK et al 2006).  
 “The study was a randomized, double blind, placebo (PL)-
controlled crossover trial, lasting 5 wks. A small dose of melatonin given 
daily, administered in the afternoon, advanced the sleep timing in 
teenagers. Twenty-one students, aged 14–19 yrs, with sleep-onset 
difficulties during school weeks were recruited During the first 6 days in 
wks 2 and 4, the students received either PL or melatonin (1 mg) capsules 
between 16:30 and 18:00 h. During the first 6 days of wk 5, all students 
received melatonin. Wks 1 and 3 were capsule-free. Primary analysis 
over 5 wks gave significant results for melatonin, sleep and KSS 
(Karolinska Sleepiness Scale,). Post hoc analysis showed that reported 
sleep-onset times were advanced after melatonin school weeks compared 
with PL school weeks ( p < .005) and that sleep length was longer ( p < 
.05). After the last melatonin school week, the students fell asleep 68 min 
earlier and slept 62 min longer each night compared with the baseline 
week. Morning melatonin values in saliva diminished compared with PL 
( p < .001) and evening values increased ( p < .001), indicating a possible 
sleep phase advance. Compared with PL school weeks, the students 
reported less wake up ( p < .05), less school daytime sleepiness ( p < .05) 
and increased evening sleepiness ( p < .005) during melatonin weeks. The 
concluded that a small dose of melatonin given daily, administered in the 
afternoon, could advance the sleep timing and make the students more 
alert during school days even if they continued their often irregular sleep 
habits during weekends (Berndt Eckerberg,1 et al 2012)”. 
 “A double-blinded study involving One-hundred ninety-two adults 
(n = 127 women, 65 men; mean age, 46 years) with insomnia on an 
outpatient basis conducted in department of Neurology Northwestern 
University Feinberg School of Medicine, Evanston, IL. Both doses of 
melatonin (0.3 or 3.0 mg) advanced the circadian phase of endogenous 
melatonin. The magnitude of phase advance in dim-light melatonin onset 
correlated strongly with the time of melatonin administration, with earlier 
times being more effective (r2 = 0.94, P < .0001).These results indicate 
that melatonin advances the circadian clock and sleep in patients with 
DSPS in a phase-dependent manner (Mundey K et al 2005). 
 
 
 
 
  
AIMS AND OBJECTIVES 
  AIM & OBJECTIVE OF THE STUDY 
 The primary aim of the study is to investigate the pattern of sleep 
among shift workers and compare their sleep parameters and salivary 
melatonin levels with the day workers. 
Objectives: 
1. To assess the polysomnographic parameters during sleep in shift 
and day workers 
2. To assess the salivary melatonin level in shift and day workers 
3. To assess the subjective measure of daytime time sleepiness in 
shift workers using Epworth Sleepiness Scale 
4. To assess the subjective measure of quality of sleep using 
Pittsburgh Sleep Quality Index 
 
 
 
 
 
 
MATERIALS AND 
METHODS 
MATERIALS AND METHODS 
 The study was conducted during the year 2014 at the Institute of 
Physiology and Experimental Medicine, Madras Medical College after 
getting approval from Institutional Ethics Committee (IEC), Madras 
Medical College Chennai. 
Selection of subjects  
 Thirty subjects on rotational shift work with working hours other 
than 7 am to 7 pm duration of not less than 6 months were selected 
between age group 20 to 40 years of male gender. Thirty normal day shift 
workers working on 7 am to 7 pm basis were taken as controls matching 
age working in offices. 
Inclusion Criteria: 
Patients  both men and women in the age group of 20 – 40 years 
working on shift work pattern not less than 6 months 
Exclusion Criteria: 
Patient with the following conditions were excluded from the study: 
Obstructive sleep disorder,  
Patients with known psychiatric illness, or  
Patients on sleep medications,  
Pregnancy,  
Post-partum period  
Subjects with neoplastic, hepatic, diabetic, respiratory and any 
cardiovascular disorder or other concurrent medical illness (i.e. 
respiratory and heart failure and renal disease) 
 Patients with secondary infections 
 In addition those under medications which affect sleep were also 
excluded. 
 Controls were age matched healthy subjects with normal sleep 
habits. 
 With these criteria a total of 60 individuals of male gender were 
selected. Of this 30 were rotational shift workers and remaining 30 were 
day workers. After thorough explanation of the study, informed verbal 
and written consent was obtained from the participants, and 
polysomnography (PSG) was conducted when patient is in stable 
condition. 
STUDY DESIGN: cross sectional study 
TYPE OF STUDY: comparative study 
PLACE OF STUDY: Institute of Physiology and Experimental Medicine, 
Madras Medical College, Chennai 03.  
POLYSOMNOGRAPHY 
STUDY OF NORMAL SLEEP 
There are mainly two ways to define the stages of sleep 
A. Clinical observations 
B. Physiologic information 
 The term polysomnography was coined by Holland, Dement, and 
Raynall in 1974 a common method employed to study these changes by 
recording of  Electro encephalogram (EEG), Electro oculogram (EOG), 
Electromyogram (EMG), Electrocardiogram (EKG), vital signs and 
breathing parameters. Polysomnography is a comprehensive recording of 
the biophysiological changes that occurs during the sleep. 
Polysomnography is usually performed during the night when patient 
sleeps. Polysomnography is the technique of recording analyzing and 
interpreting multiple simultaneous physiologic parameters during sleep. 
Scientific effort was made to characterize all the physiological events that 
occur during sleep and provide a standardized scoring manual with 
universally accepted terminology and specifications.  
 The manual for the recording and scoring of human sleeping 
activity was published by A.Rechtschaffen and A.Kales in 1968. 
Technical advancement, digitization, and discovery of multiple new 
concepts in sleep medicine, led to incorporation of more comprehensive 
scoring rules and terminologies by the American Academy of Sleep 
Medicine (AASM) in 2007. It framed standardized review for 
specifications, rules for scoring normal sleep and terminology for the 
evaluation of pathological findings during sleep. AASM uses the term N 
for NREM sleep stages and R for REM sleep stages, N1 and N2 are used 
for stage 1 and stage 2; N3 indicates the sum of stage 3 and stage 4. Yet 
another change is regarding to the nomenclature for recording 
placements, calling the post auricular placements M1 and M2 (rather than 
A1 and A2). 
 The night is divided into epochs time for convenience so that it 
corresponds to the length of each paper page. The paper speed for speed 
recording is 10 mm/s ; a 30 –cm page corresponds to 30 s. the segment of 
time represented by each page is called an epoch. Sleep stage scoring is 
done in epochs. With technical and digital advancements, sleep recording 
at present is done digitally but still sleep is scored conventionally using a 
30 second epoch window. 
 Clinical polysomnogram in addition to these variables is used to 
diagnose various sleep disorders through airflow monitors of nasal and 
oral cavity, respiratory effort gauges placed around chest and abdomen, 
pulse Oximetry – non invasive measure of oxygen saturation, 
electrocardiogram, EMG of anterior tibialis muscle to detect periodic 
limb movements and audiovisual means to monitor patient’s gross body 
movements. According to the International Classification of Sleep 
Disorders (AASM, 2005), there are 90 distinct sleep disorders. Nasal 
pressure sensors connected to the nose via nasal prongs are accurate in 
recording apnoea and hypopnoea when compared to thermal sensors 
(Series F, Mrc I, 1999). During inspiration , airway pressure is negative 
relative to atmospheric pressure and during expiration , it is relatively 
positive. The resulting alteration in nasal airway pressure can provide a 
surrogate estimate of airflow.  
 Respiratory effort is monitored using respiratory inductance 
plethysmography which detects changes in inspiratory and expiratory 
volumes by chest and abdominal wall motion. It also helps to distinguish 
between central apnoeic event which is not associated with respiratory  
effort and obstructive apnoeic event where a phase shift in respiratory 
effort is recorded. The abdominal wall moves outward due to the descent 
of the diaphragm while the thoracic wall moves inward due to the 
negative pressure generated by upper airway collapse. 
 Transcutaneous pulse Oximetry is used to record different 
parameters such as total number of desaturations, oxygen desaturation 
index (ODI), number of desaturation per hour , lowest SpO2, and total 
time SpO2 spent below 90%. A 4% fall in saturation is considered to be a 
significant measure of hypopnoea. Oxygen saturation is the oxygen 
content of blood divided by oxygen capacity and expressed in volume 
percent. The desaturation recorded  is delayed after a respiratory event 
because of the circulation time from the heart to the finger. The normal 
delay is about 10 to 12 seconds . 
 Components of polysomnography recording system include : 
 Quality amplifier 
 Filter design and configuration  
 Independent filter selections for each channel  
 Adequate sampling rates and bit resolution for each recorded 
parameter 
 Input signal referencing capabilities  
 Provisions for standard calibration procedures and signal 
verification  
 Appropriate signal display 
 Polysomnography may be digital or analog type. The digital 
systems are computer based instruments. It has adequate storage capacity 
. a typical device might require 50 megabytes of storage for an 8 hour 
recording. Data are usually downloaded onto a computer system separate 
from the recording device. 
SIGNAL SOURCE 
There are three sources of signals:  
 Bio electric potentials example EEG, EOG, EMG, ECG 
 Trasnduced signals from sensors attached to the patient example 
signal obtained from respiratory, snoring  and body position 
sensors. 
 Ancillary equipment signals example Oximeter. These separate 
instruments have their own processing circuits, signal display and 
signal outputs.  
 
  There are two types of amplifier – alternating current amplifier to 
record physiologic parameter of high frequency example EEG, EOG, 
EMG, ECG and a direct amplifier to record slowly changing potentials as 
signal from pulse Oximeter. 
DIFFERENTIAL AMPLIFIER 
It amplifies the difference between electrode inputs rather than the 
absolute voltage at any electrode. 
The electrical noise present at both the electrode is subtracted out 
and therefore does not contaminate the recording. 
The ability of the amplifier to suppress a signal such as noise, that 
is present simultaneously at both the electrodes is called common mode 
rejection. 
FILTERS: 
 The differential amplifier eliminates most of the unwanted signals 
and the remaining unwanted signals are removed by the use of filters. 
Filters are of the following types: 
High frequency filter (HFF)- it determinates the upper limit of 
frequencies that a channel displays at full amplitude . the amplitude of the 
electrical signal with frequencies greater than HFF settings is attemuated. 
Low frequency filter (LFF)- it determinates the lower limit of 
frequencies that a channel displays at full amplitude. The amplitude of the 
electrical signal with frequencies lower than LFF settings are attenuated. 
Notch filter – 50/ 60 Hz filters are provided as a temporary means 
of eliminating 50 or 60 Hz frequency interference from amplifier output. 
Digital filter - it uses software algorithms to delete selected 
frequencies after the amplified signals have been converted into digital 
form. 
 PATIENT TRAY CONSISTS OF  
EEG paste 
Measuring tape 
Cotton swabs 
Electrodes, sensors, and lead wires 
Spirit 
Micropore 
Gloves 
Scissors 
  
 
  
DIGITAL SPECIFICATION FOR ROUTINE 
POLYSOMNOGRAPHY (AASM GUIDELINES) 
 
Electrode Desirable 
sample 
rate(Hz) 
Minimal 
sampling 
rate (Hz) 
High 
frequency 
filter (Hz) 
Low 
frequency 
filter (Hz) 
Maximum 
impedance 
(K Ohms) 
EEG 500 200 35 0.3 5 
EOG 500 200 35 0.3 5 
EMG 500 200 100 10  
EKG 500 200 70 0.3  
Snoring 500 200 100 10  
Airflow 100 25    
Oximetry 25 10    
Chest and 
abdominal 
movement 
100 25    
Body 
position 
1 1    
 
SIGNAL MEASUREMENT 
The recorded signal can be measured according to  
1. Frequency- frequency is described as cycles per second or Hertz 
which refers to the number of waves appearing in the span of one 
second. 
2. Amplitude – Amplitude refers to the vertical height of a wave and 
represents electrical voltage of the wave. It depends on the 
sensitivity setting of amplifier .  
Sensitivity is defined as the amount of voltage necessary to 
produce a set deflection of the pen. Greater the sensitivity, lesser is the 
recorded amplitude. 
REQUIREMENTS FOR CONDUCTING POLYSOMNOGRAPHY 
• Air conditioned room with attached bathroom 
• Polysomnographic recording system  
• Computer 
• Amplifiers 
• Electrodes and application material 
• Pulse oximeter-to detect blood gas analysis 
• Abdominal and thoracic belts-to detect respiratory effort 
• Nasal airway pressure transducer- to detect nasal airflow 
• Access to emergency medical care 
Prestudy procedure: 
• Detailed sleep wake history is taken 
• a complete medical history and clinical examination should 
be completed 
• information is provided to the patient about the purpose and 
procedure of sleep study 
• Patient should be made aware that their sleep will be 
monitored throughout the entire study and they should be 
told how to contact the technologist if necessary. 
The patient was asked to follow the instructions: 
• To take a bath in the evening and shave of facial hair  
• Not to apply oil anywhere on the body 
• To take dinner at least one hour before sleep study 
• Not to consume alcohol on the day of study 
• Avoid coffee or tea at least 3 hours before the study 
• Dress in routine sleep wear 
• Remove all ornaments 
• To bring all previous medical reports 
• Report for sleep study at the appointed time 
SLEEP STUDY PROCEDURE: 
Patient hookup: - it involves placement of various sensors to record the 
different parameters during sleep. 
ELECTROENCEPHALOGRAM: 
 EEG is the surface recordings of the summation of excitatory and 
inhibitory postsynaptic potentials generated by pyramidal cells in cerebral 
cortex. The advantage of EEG recordings in research is their non – 
invasive nature and high temporal resolution so that changes of even a 
few milliseconds can be detected. Recordings reveal subtle differences in 
brain function,  which are not always accompanied by behavioural 
performance. 
 The disadvantage is their low spatial resolution and they only 
reflect synchronous electrical activity of large neural assemblies. 
Contamination of EEG recordings by artifacts (eye or head movements, 
muscle movements, and external electrical noise) compromises the 
interpretation of the data if such artifacts are not removed. The EEG is 
recorded using six “exploring” and two “reference” electrodes. 
 The acceptable derivation for the purpose of scoring sleep stages 
are C3 or C4 referred to opposite mastoid; two channels are recorded with 
one used as backup for technical problems during night. The opposite 
side derivation is used to maximize inter electrode distance as amplitude 
of EEG is dependent on inter electrode difference and the criteria for 
scoring sleep stages III and IV are dependent on amplitude. 
 International 10 -20 system was developed as a standard 
measurement tool for placing electrodes on the head for recording EEG. 
The following electrode sites are located according to R&K criteria – two 
mastoid ( known as aural , A1, A2), two central (C3, C4) and two 
occipital (O1, O2) . EEG is recorded using either gold cup or silver 
chloride electrodes. Electrode impedance should ideally be less than 500 
ohms. Standard gain for EEG electrodes is a deflection of 1 cm for every 
50 µv.  Recommended EEG deviations are : C4-A1, O2-A1, with C3-A2 
as a backup.  
STEPS IN INTERNATIONAL 10-20 ELECTRODE PLACEMENT 
SYSTEM 
 Location for four landmarks-nasion, inion, left preauricular region , 
and right preauricular region. 
 The distance from nasion to inion was measured. The 10 % of total 
distance from nasion is marked as Fpz and from inion as Oz along the 
line joining them. The halfway point between nasion and inion is marked 
as Cz. 20 % distance from Cz in front is marked as Fz and back as Pz. 
 The distance between left and right preauricular point was measure, 
with the tape passing through the halfway mark of Cz. From the Cz 20 % 
of the distance on the left is marked as C3 and right as C4 on the line 
joining the left and right preauricular points. 
 The circumference of the head is measured by passing the through 
all the 10% marks. 50% of this measurement coincides with Oz at the 
back and Fpz in the front. 5% of circumference to the left of Oz is marked 
as O1and right as O2. Similarly 5% circumference to left of Fpz is 
marked as Fp1 and right as Fp2. 
 The distance from Fp1 to O1 passing through C3 is measured. 
50%of this distance should intersect at C3. 25% of this distance is marked 
on the line joining Fp1and C3 as F3 and similarly on the right side as F4. 
 A1 and A2 are placed behind the ears on the mastoid process. 
 For recording the electro oculogram, the placement of an electrode 
is located 1 cm out and below the outer canthus of the left eye (E1) and 
another electrode placed 1 cm out and above the  outer canthus of right 
eye (E2) with reference to the right mastoid process (A2). It records the 
retino- corneal potential difference . 
 For recording the electromyogram of the chin ,two electrodes are 
placed just below the chin , one electrode placed 2cm below and 2cm left 
of midline and the others is 2cm below and 2cm to the right of midline. 
 Respiratory effort belts are placed snugly around the thorax and 
abdomen. 
 Airflow sensors- Nasal prongs connected to a pressure transducer 
is used for measuring nasal flow (gives an indirect measure of flow based 
on the recording of the pressure at the gives an indirect measure of flow 
based on the recording of the pressure at the prongs relative to the 
atmospheric pressure.) 
 Oximeter sensor is placed on any of the three middle fingers. It is a 
noninvasive method for monitoring the hemoglobin percentage saturated 
with oxygen. Snore sensor is also connected. 
 Leg EMG leads records activity of anterior tibialis muscle. 
Electrodes are placed on the outer aspect of lower half of each leg. 
 
 Figure 6 10 -20 system of electrode placement for EEG 
PARAMETERS RECORDED: 
• ELECTROENCEPHALOGRAM 
• CHIN ELECTROMYOGRAM 
• ELECTRO OCULOGRAM 
• ELECTROCARDIOGRAM 
• AIRFLOW 
• ABDOMINAL AND THORASIC RESPIRATORY 
EFFORT 
• LEG/ARM ELECTROMYOGRAM 
• SATURATION 
• SNORING 
• BODY POSITION 
• HEART RATE 
After all sensors are applied, the impedance and signal of all the 
electrodes was checked. Physiologic biocalibration was done at the start 
of the study before lights out and just after lights on at the end of the 
study. 
Close eyes-instruct patient to lie down with eyes closed for 30 
seconds. This helps to reveal the alpha activity. 
Open eyes-instruct patient to lie still down with eyes open for 30 
seconds. This helps to eliminate the alpha activity. 
Look left and right- instruct patient to look to left and right 
repeatedly while holding the head still. This mimics the eye movement 
seen during REM sleep 
Look up and down- instruct patient to look to the up and down 
repeatedly while holding the head still. This differentiates the vertical and 
horizontal eye movements. 
Hold breath-Instruct the patient to take a deep breath and hold it for 
5-10 seconds. This mimics the central apnoea 
Respiratory effort- Instruct he patient to move the chest and 
abdomen in and out while holding breath. This mimics an obstructive 
apnoea. 
Move feet- Instruct the patient to move the feet. This mimics leg 
movements during sleep. 
During the study the observer should document 
Time of sleep study 
Biocalibration 
Technical difficulties and methods of correction 
Patient complaints 
Post study procedure 
 Ensure that study is saved properly 
 Clean and sterilize the electrodes  and various sensors 
Scoring and data analysis is done to recognize the following events 
Sleep staging 
Arousal 
Cardiac events 
Respiratory events 
Movement events 
SCORING BY EPOCHS 
 The polygraph record is divided into segments of equal size, with 
epoch length of 300mm and duration of 30 seconds. 
 A single stage score is assigned to each epoch-when more than one 
stage is present in each epoch-the stage score of the epoch is determined 
by the stage that takes up the greatest portion of the epoch. 
SLEEP STAGES SCORING 
 Sleep stage are scored at 30 sec sequential recordings known as 
epochs. 
 Wake – A>50% of an epoch has alpha EEG waves over the 
occipital region with eye closure or if alpha waves absent the presence of 
any of the following 
 Eye blinks (0.5-2Hz) 
 Reading eye movement which consists of slow conjugate 
movement followed by a rapid movement in the opposite direction, 
 Rapid open eye movements associated with normal or high chin 
tone. 
Stage-I- alpha waves being replaced by a low amplitude , mixed 
frequency (4 to 7Hz) waves occupying >50% of the epoch, or the 
presence of (for those who do not generate alpha waves) 
 Vertex sharp waves of <0.5 seconds duration that are maximal over 
central region 
 Slow eye movement 
Stage II- defined by the presence of K complexes or sleep spindles. 
Stage III and IV – indicated when >=20%of the epoch shows slow 
wave (0.5-2Hz and >75uV) EEG activity. 
REM – presence of low amplitude, mixed frequency EEG activity , 
rapid eye movement on EOG, and low tone on EMG. 
 
 Figure 7  Epoch of awake stage 
 Figure 8 Epoch of stage N1 
 Figure 9 Epoch of stage N2 
 Figure 10 Epoch of stage N3 
 Figure 11 Epoch of stage N4 
 Figure 12 Epoch of Rapid Eye Movement stage 
RESPIRATORY EVENTS SCORING RULES: 
APNOEA-decrease in airflow amplitude by =>90% from baseline for a 
duration of minimum10 seconds. It is scored as 
Obstructive-if inspiratory effort is present throughout the entire period 
Central -if the inspiratory effort is absent throughout the period 
Mixed –if inspiratory effort in the initial part of the period is followed by 
the presence of inspiratory effort. 
Hypoapnoea-decrease in airflow amplitude by =>30% of baseline for 
duration of at least 10 seconds accompanied by =>4% of oxygen 
saturation. 
Arousal 
During NREM sleep – abrupt frequency shift (eg.alpha , theta or 
frequencies >16 Hz) lasting =>3 seconds and preceded by =>10 seconds 
of stable sleep. 
During REM sleep abrupt EEG frequency shift (e.g alpha, theta, or 
frequencies >16 Hz) lasting =>3 seconds and  preceded by =>10 seconds 
of stable sleep, accompanied by an increase in chin EMG that is =>1 
second duration. 
Respiratory Effort Related Arousal (RERA)- breaths associated with 
heightened respiratory efforts or flat  airflow waveform with a duration 
=>10 seconds and preceding an arousal but not meeting criteria for either 
apnoea or Hypoapnoea. 
Periodic limb movement in sleep 
 Four consecutive leg movements (each 0.5 to 10 seconds in 
duration with an amplitude 8uV above resting EMG) characterized by 
period lengths of between 5 and 90 seconds between onset of consecutive 
movements. 
 Leg movements on different legs are counted as one  movement if 
they are separated by <5 seconds between movement onsets. 
SLEEP ARCHITECHTURE DEFINITION AND FORMULAE 
% Stage I   = Minutes of Stage I *100/ Total 
SleepTime (TST) 
% Stage II    = Minutes of Stage II *100/ Total 
Sleep Time(TST) 
% Stage III & IV  = Minutes of Stage III&IV *100/ 
Total Sleep Time(TST) 
% Stage R = Minutes of Stage R *100/ Total 
Sleep Time(TST) 
% Wake time = Minutes of  Wake *100/ Sleep 
Period Time (SPT) 
Sleep Onset = The first three consecutive Epochs 
of Stage I sleep 
Latency to REM = The period of time from sleep onset 
to first Epoch of REM  
NAP onset (Sleep) 
latency 
= the period of time to lights out to 
sleep onset 
Sleep Period Time 
(SPT) 
= The time from sleep onset to last 
Epoch of sleep 
Total Recording Time 
(TRT) 
= The time from lights out to lights on 
Total Sleep Time 
(TST) 
= The amount of sleep recorded 
during TRT 
Wakefulness After 
Sleep Onset (WASO) 
= The Wakefulness occurring from 
sleep onset to last Epoch of sleep 
OTHER INDICES 
Apnoea Hypoapnoea 
Index (AHI) 
Total number of apnoeas and Hypoapnoeas 
occurring per hour of sleep 
Respiratory 
Disturbances Index 
(RDI) 
Total number of apnoeas and Hypoapnoeas 
and Respiratory Effort Related Arousals 
occurring per hour of sleep 
Desaturation Index Total number of desaturation events per hour 
of sleep 
 
 
 
4.3SUBJECTIVE SLEEP ASSESSMENT QUESTIONNAIRES  
 
 
  
4.4 ESTIMATION OF SALIVARY LEVELS OF MELATONIN  
 “Traditionally, serum has been used for analysis of melatonin, but 
there are practical limitations with using this type of measurement in the 
home or the workplace, particularly when repeated samples are needed to 
estimate the time of the melatonin peak. Overnight or first-void urine 
specimens are also widely used, and although reliable for information on 
overnight melatonin production107108(Travis RC et al 2003; 
Schernhammer ES et al 2004). They do not provide information on the 
24-hour variation in levels. For the purposes of this study, multiple 
samples of saliva provided a simple and reliable measure of daily patterns 
of melatonin levels109110 (Voultsios A et al 1997; Nagtegaal E et al 1998), 
which was more practical than repeated urine or serum samples for use in 
occupational and residential settings. Even in the elderly, where hypo 
salivation and lower melatonin levels limit feasibility, salivary melatonin 
assessment was correlated with serum melatonin (Spearman rho _ 0.659, 
P _ 0.001) 111”. 
  
4.4.1 Collection of saliva 
 
  
 
 
 
 
The participants are given instructions about collection of saliva in 
sterile tube along with sterile cotton swabs. The night workers 30 out of 
30 were agreed to sample their saliva, while in the work in their call 
center were advised to collect saliva samples on precise time 8 pm, 10 
pm, 12 am, as instructed prior, with light level maintained constantly dim 
< 10 lux, such that endogenous secretion of melatonin was not 
suppressed. Soon after the collection of saliva cotton swabs were 
disposed safely and the samples were transported maintaining -20 degree 
c until they are stored in a deep freezer with -20 degree c. Saliva samples 
were frozen and then stored at -20°C until they were shipped frozen to 
TamilNadu Dr.MGR Medical University for melatonin levels determined 
by ELISA reader. 
4.4.2 Storage of samples 
 
 A well maintained deep freezer with -20 degree c was available in 
the Institute of Physiology and Experimental Medicine, Madras Medical 
College, Chennai. All the samples were stored in the deep freezer until 
estimation of salivary melatonin. 
4.4.3 Estimation of salivary melatonin: 
 Estimation was done using Human melatonin ELISA kit CSB-
E08132h Cusabio  Biotech Co., LTD. Dongou Hi-tech Development 
Area, Wuhan, Hubein province, P.R China (refer photograph 2).  
  
Principles of assay: 
 “This assay employs the quantitative sandwich enzyme 
immunoassay technique. Antibody specific for MT has been pre-coated 
onto a microplate. Standard and samples are pippeted into the wells and 
any MT present is bound by the immobilized antibody. After removing 
any unbound substances, abiotin –conjucated antibody specific for MT is 
added to the wells. After washing, avidin conjucated Horshdish 
peroxidase (HRP) is added to the wells. Following  a wash to remove any 
unbound avidin-enzyme reagent, a substrate solution is added to the wells 
and color develops in proportion to the amount of MT bound in the initial 
step. The color development is stopped and the intensity of the color is 
measured by ELISA reader values plotted to get the MT concentration”. 
Contents of the kit  
1. Wash  Buffer 
2. Biotin antibody and its diluent 
3. HRP avidin and its diluent 
4. Standard 
5. TMB substrate 
6. Stop solution 
7. Sample Diluent 
 STATISTICAL ANALYSIS  
 The data collected were subjected to Statistical analysis using the 
software SPSS version 21. 
Student’sT test was carried out to compare the means of variables 
between day worker sand shift workers. 
  
RESULTS 
RESULTS 
TABLE I 
Comparison of parameters between Day worker and Shift worker 
Variable Group N Mean 
Age 
Day worker 30 21.33±0.48 
Shift worker 30 24.97±2.55 
BMI 
Day worker 30 22.81±1.65 
Shift worker 30 24.04±1.64 
 
TABLE II 
Comparison of Sleep Efficiency between Day worker and Shift worker 
 
Variable Group N Mean SD P -Value 
SLEEP 
EFFECIENCY 
Day worker 30 91.52 3.71 
.0001** Shift 
worker 
30 83.81 7.38 
**    P – Value  < 0.001 Very Highly Significant 
 
The Sleep Efficiency percentage of shift worker shows a very 
highly significant decrease (**P-Value < 0.001) when compared to day 
worker 
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 TABLE III 
Comparison of Sleep Stage I between Day worker and Shift worker 
 
Variable Group N Mean SD P -Value 
Sleep stage 
I 
(Minutes) 
Day worker 30 20.9 5.59 
0.193 Shift 
worker 
30 22.77 5.38 
*    P – Value  < 0.05 Significant 
 
The Sleep stage I of shift worker shows a decrease but not 
significant (P-Value 0.193) when compared to day worker 
 
TABLE IV 
Comparison of Sleep Stage II between Day worker and Shift worker 
 
Variable Group N Mean SD P -Value 
Sleep stage 
II 
(Minutes) 
Day worker 30 203.67 14.93 
0.617 
Shift worker 30 205.65 15.60 
*    P – Value  < 0.05 Significant 
 
The Sleep stage II of shift worker shows a decrease but not 
significant (P-Value 0.617) when compared to day worker 
 
 
` 
 
 
 
 
 
 
 
 
  
 TABLE V 
Comparison of Sleep Stage III between Day worker and Shift worker 
 
Variable Group N Mean SD P –Value 
Sleep stage 
III 
(Minutes) 
Day worker 30 39.28 5.99 
0.017* 
Shift worker 30 35.40 6.25 
*    P – Value  < 0.05 Significant 
 
The Sleep stage III of shift worker shows a significant decrease 
(*P-Value) when compared to day worker 
 
TABLE VI 
Comparison of Sleep Stage IV between Day worker and Shift worker 
 
Variable Group N Mean SD P –Value 
Sleep stage 
IV 
(Minutes) 
Day worker 30 42 8.11 
0.07 
Shift worker 30 38.13 8.49 
*    P – Value  < 0.05 Significant 
 
The Sleep stage IV of shift worker shows a decrease but not 
significant (P-Value 0.07) when compared to day worker 
  
 
 
 
 
 
 
 
 
 
 
  
 TABLE VII 
Comparison of REM Sleep Stage between Day worker and Shift worker 
 
Variable Group N Mean SD P –Value 
REM Sleep 
Stage 
(Minutes) 
Day worker 30 80.47 10.10 
.0001** 
Shift worker 30 64.03 11.58 
**    P – Value  < 0.001 Very Highly Significant 
 
The REM Sleep Stage of shift worker shows a very highly 
significant decrease (**P-Value) when compared to day worker 
 
TABLE VIII 
Comparison of NAP onset latency between Day worker and Shift worker 
 
Variable Group N Mean SD P –Value 
NAP onset 
latency 
(Minutes) 
Day worker 30 13.25 4.69 
.0001** 
Shift worker 30 19.73 3.26 
**    P – Value  < 0.001 Very Highly Significant 
 
The NAP onset latency of shift worker shows a very highly 
significant increase (**P-Value) when compared to day worker 
  
 
 
 
 
 
 
 
 
 
  
 TABLE IX 
Comparison of Sleep Stage Percentage between Day worker and Shift 
worker 
 
Variable Group Mean SD P -Value 
Stage I % 
(Stage I/Total 
Sleep Time*100) 
Day worker 5.40% 1.41% 
0.030* 
Shift worker 6.22% 1.45% 
Stage II % 
(Stage II/Total 
Sleep Time*100) 
Day worker 52.75% 3.58% 0.001* 
 Shift worker 56.26% 4.07% 
Stage III % 
(Stage III /Total 
Sleep Time*100) 
Day worker 10.17% 1.51% 
0.224 
Shift worker 9.67% 1.68% 
Stage IV % 
(Stage  IV/Total 
Sleep Time*100) 
Day worker 10.85% 1.93% 
0.350 
Shift worker 10.37% 2.04% 
REM % 
(REM/Total Sleep 
Time*100) 
Day worker 20.82% 2.45% 
0.0001** 
Shift worker 17.47% 2.89% 
 
*    P – Value  < 0.05 Significant 
 
**    P – Value  < 0.001 Very Highly Significant 
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TABLE X 
Comparison of NAP time between Day worker and Shift worker 
 
Variable Group N Mean SD P -Value 
NAP time 
Day worker 30 386.32 16.69 
.0001** Shift 
worker 
30 365.98 20.62 
**    P – Value  < 0.001 Very Highly Significant 
 
TABLE XI 
Comparison of subjective sleep scores between Day worker and Shift 
worker 
 
Variable Subjects Questionnaires Mean SD P -Value 
Subjective 
sleep 
scores 
day worker PSQI 0.77 1.33 
0.000** 
shift worker PSQI 4 2.69 
day worker ESS 6.23 2.21 
0.009* 
shift worker ESS 8.56 4.22 
* P value < 0.01 highly significant 
**    P – Value  < 0.001 Very Highly Significant 
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 TABLE XII 
Comparison of salivary melatonin level (pg/ml) between Day 
worker and Shift worker 
 
Salivary 
melatonin 
Worker Number Mean SD P – Value 
Melatonin 
8 pm 
Day 15 3.97 0.42 
0.295 
Shift 15 3.77 0.56 
Melatonin 
10 pm 
Day 15 5.74 0.34 
0.000** 
Shift 15 4.89 0.66 
Melatonin 
12 am 
Day 15 6.85 0.18 
0.000** 
Shift 15 5.83 0.25 
**    P – Value  < 0.001 Very Highly Significant 
 
  
  
 
 
 
0
1
2
3
4
5
6
7
8:00 PM 10:00 PM 12:00 AM
3.97
5.74
6.85
3.77
4.89
5.83
day worker
shift worker
DISCUSSION 
DISCUSSION 
 This study was done to record the sleep stages and find the salivary 
melatonin secreting pattern between day workers and rotating shift 
workers along with their subjective sleep scores. The mean age of the 
study groups were comparable 21.33±0.48 for day workers and 
24.97±2.55 for shift worker as well as the body mass index for day 
worker (22.81±1.65) and shift worker (24.04±1.64). None of them were 
obese by means of BMI. Both the group persons were subjected to 
polysomnography for a minimum period of 6 hours to maximum period 
of 8 hours. The obtained data were analyzed statistically and independent 
sample T test was used to obtain the significance. 
Scoring of sleep stages: 
 Sleep stages were interpreted with respect to the duration of each 
sleep stage, latency onset of sleep stage, total sleep duration and sleep 
efficiency. Total sleep time was recorded as the sum of all 30 second 
epochs of REM and non REM sleep. The mean total sleep time (NAP 
time) for day worker 386.32 ±16.69 minutes shift worker 365.98±20.62 
minutes. These results were consistent with the study by Akersted T et al 
1991112 and Tepas DI  et al 1981113. 
 The mean Sleep Efficiency percentage of shift worker shows a very 
highly significant decrease 83.81±7.38% when compared to day worker 
91.52±3.71 %. This may be a cause of sleep maintenance insomnia in 
shift workers in whom internal circadian rhythm is desynchronized. 
However SE did not differ between shifts in the study done by Akersted 
T et al  1991 and Dahlgren K  et al 1981114. 
  Sleep stage I of shift worker 22.77±5.38 minutes of mean value 
shows a decrease but not significant when compared to day worker 
20.9±5.59 minutes. Sleep stage II of shift worker shows a decrease but 
not significant, when compared to day worker 203.67±14.93 minutes, 
shift worker 205.65 ± 15.60 minutes. Similar decrease in stage II was 
obtained in the study done by Akersted T et al 1991. Excessive day time 
sleepiness is associated with increase in sleep stage I increased arousal 
frequency leading to loss of continuity in sleep, decrease in duration of 
slow wave sleep and REM sleep which is consistent with the results of 
the study (Alexandros N.Vgontzas et al., 1994) 115. 
 Sleep stage III of shift worker shows a significant decrease when 
compared to day worker, 39.28 ±5.99 minutes, shift worker 35.40±6.25 
minutes. Sleep stage IV of shift worker shows a decrease but not 
significant when compared to day worker, 42±8.11 minutes, shift worker 
38.13±8.49 minutes. These slow wave sleep were found to be decreased 
in the study done by Akersted T et al 1991 and Torsvall L et al 1981116 .  
  Rapid Eye Movement Sleep Stage of shift worker shows a very 
highly significant decrease when compared to day worker 80.47±10.10 
minutes, shift worker 64.03±11.58 minutes. Similar results were obtained 
in the study done by Akersted T et al 1991and Matsumoto K et al 
1978117. 
  NAP onset latency is defined as the duration of time between 
lights out and sleep onset, defined by consecutive epochs of stage I or 
first stage of deeper NREM stage. The NAP onset latency measured in 
minutes for shift worker shows a very highly significant increase when 
compared to day worker 13.25±4.69 minutes, and shift worker 
19.73±3.26 minutes. This may be related to sleep onset insomnia as 
commonly reported in sleep clinics by employees. The result was 
consistent with the study done by Foret J et al 1972118. 
 The mean percentage value of the sleep stages showed reduction in 
deep  slow wave sleep and rapid eye movement stage, there by occupying 
the counter portion by the stage I & II as the following : Sleep stage I day 
worker 5.40%±1.41%, shift worker 6.22%±1.45%,  Sleep stage II day 
worker 52.75% ±3.58%, shift worker 56.26% ± 4.07%, Sleep stage III 
day worker 10.17% ± 1.51%, shift worker 9.67% ±1.68%, , Sleep stage 
IV day worker 10.85%±1.93%, shift worker 10.37% ± 2.04%, stage REM 
day worker 20.82% ±2.45%, shift worker 17.47% ± 2.89%. Similar 
results were obtained in the study done by Torsvall L  et al 1989119.  The 
slow wave sleep is reduced and the part is occupied by stage 1 & 2 of 
sleep. 
 Subjective sleep scores for shift workers 4±2.69 for PSQI were 
higher than for the day worker 0.77± 1.33, as well as higher scores for 
ESS obtained for shift worker 8.56±4.22 as compared to day worker 
6.23±2.21, showing poor quality of sleep for shift workers and more 
prone for dozing during the period when he usually is awake. These 
results were consistent with the study by Tilley AJ et al 1982120. 
 Melatonin secretory pattern in saliva showed a lower trend for shift 
worker as evidenced by salivary melatonin ELISA assay Shift worker  
8pm 3.77±0.56 10 pm 4.89±0.66  12 am 5.83 ± 0.25 (in pg/ml) as 
compared to day worker 8pm 3.97 ±0.42 10pm 5.74± 0.34, 12 am 
6.85±0.18 (in pg/ml). The limitation of the study is base line secretion of 
melatonin prior to 20:00 and melatonin concentration after 00:00 were 
not measured. Therefore DLMO occurred beyond this interval could have 
been missed. A study done by gooneratne et al121 stated that mean DLMO 
was 21:00 under strict dim light conditions in eighty-five subjects. The 
difference in time line trend of melatonin secretion between the day and 
shift workers during dim light may be an association with disrupted 
circadian rhythms in rotating shift workers, which are further supported 
by the melatonin results.  
 There was no significant difference in the melatonin level at 8 pm, 
between shift and day worker. But melatonin levels at 10 pm and 12 am 
were found to be statistically significant (p < 0.001). Melatonin levels in 
those working rotating shifts were abnormal, with low levels. This pattern 
possibly suggests that fast-rotating shifts (6 days, 6 nights, a day off 
between switch over) might not have allowed sufficient time for 
adaptation to occur.  The consequences of this are unheard of.  
 So it is unclear from this study whether rotating shift workers 
actually produce less melatonin as a result of exposure to light-at-night, 
or just at different times. It is also unknown whether exposure to 
melatonin at different times results in different physiologic effects. Our 
study was conducted with rotating male shift workers, who might be 
more compliant than their female counterpart and the average population, 
so response and acceptability may vary in other work-related groups. 
 Comparisons of self-reported data and measured data did not 
support the utility of asking shift workers about bedroom lighting, but did 
support a possible association of years of shift work with exposure to 
light at- night and abnormal melatonin levels. Self-reported data can in 
certain circumstances be more valid than exposure measurements; 
especially when only one point in time is measured, because self-report 
may take into account average exposure instead of a single snapshot in 
time122 (Teschke K et al 2002).  
 Accordingly, the bedroom lighting question could perhaps be 
improved to be more inclusive of the different conditions relevant to shift 
work, and then may show a closer association with measured light. Our 
observations must be interpreted cautiously, in light of two limitations: 
the size of the study and the use of a 3-sample measurement of salivary 
melatonin. In this study, we cannot rule out chance or potential 
confounders such as BMI, alcohol intake or co morbidities as alternate 
explanations.   
 Overnight or first-void urine specimens are also widely used, and 
although reliable for information on overnight melatonin production 
123124(Travis RC et al 2003; Schernhammer ES et al 2004), they do not 
provide information on the 24-hour variation in levels. For the purposes 
of this study, multiple samples of saliva was considered as a simple and 
consistent measure of daily patterns of melatonin levels125126 (Voultsios A 
et al 1997; Nagtegaal E et al 1998), which was more practical than 
repeated urine or serum samples for use in occupational and residential 
settings. Even in the elderly, where hypo salivation and lower melatonin 
levels limit feasibility, salivary melatonin assessment was correlated with 
serum melatonin (Spearman rho _ 0.659, P _ 0.001)127. More 
measurement time-points are desirable, and often feasible in laboratory 
studies, but in the field, the practical issue of compliance also was a 
consideration when selecting three sample times. 
 Few studies have attempted to measure light exposure directly for 
an extended period of time, or correlate such measurements with 
surrogate variables such as self reported shift work or self-reported home 
lighting levels, though in one study, melatonin was studied in night 
workers over four consecutive weeks 128 (Lowden A et al 2004). Koller et 
al129 measured light exposure in permanent night-shift workers for a 
period of 48 hours, while Dumont et al 2001130 did measurements of light 
exposure and urinary 6-sulfatoxymelatonin in permanent night shift 
nurses for a period of 56 hours, followed by 24 hours in a laboratory 
setting. Dumont and colleagues131 reported that 22 of their 30 permanent 
night nurses had a timing of melatonin secretion typical of day-oriented 
people, and that the 24-hour profiles of light exposure were very 
distinctive, similar to our observations in rotating shift workers. A cross-
sectional study in US of health and performance markers in 188 day and 
night shift health care workers 132(Demoss C et al 2004) reported an 
association with night shift work and unpredictable schedules, decreased 
energy levels, sleep disturbance and difficulty performing routine orders 
because of sleepiness or fatigue.  
 High waking and low sleeping melatonin could partly explain the 
results seen by DeMoss et al 2004133. These results contribute possibility 
of data for the study of light at-night exposure in the workplace. They 
demonstrated that larger measurement studies are feasible, and that 
rotating shift work may be associated with abnormal melatonin levels and 
irregular light exposure patterns, so its use as a surrogate is supported by 
the data.  
 Shift work is related to possible differences in light-at-night 
exposure, and may be a valid surrogate measure, but this needs to be 
confirmed with larger studies, wherein it will be important to look at both 
rotating shift and straight night-shift work. The high waking melatonin 
levels may contribute to problems of fatigue and alertness, which might 
be addressed by interventions such as exercise134(Barger LK et al 2004), 
or exposure to bright light during work and wearing dark glasses after 
work to improve adaptation to shift work 135(Boivin DB et al 2002). The 
low levels of melatonin during sleep may be addressable with exogenous 
melatonin136 (Arendt J et al 2005), though no long-term safety, dosing or 
formulation data yet exist. 
 
  
CONCLUSION 
CONCLUSION 
The following conclusions have been derived from the study: 
 The Sleep Efficiency percentage of shift worker shows a 
significant decrease when compared to day worker  
 The Sleep stage I, II and IV of shift worker shows a decrease but 
not significant when compared to day worker indicate 
 The Sleep stage III of shift worker shows a significant decrease 
when compared to day worker indicate shift worker does not 
undergo a satisfactory deep sleep, which make them feel 
unrefreshed while in wake period after day time sleep. 
 The REM Sleep Stage of shift worker shows a significant decrease 
when compared to day worker  
 While in the view of percentage wise occupation of sleep stages, 
rapid eye movement stage and slow wave sleep were reduced and 
the counterpart occupied by the stage I , II and III. 
 The NAP onset latency of shift worker shows a significant increase 
when compared to day worker denoting the cumulative lack of 
sufficient sleep in shift workers. 
 Subjective self rated sleep scores (PSQI & ESS) showed increased 
values for shift workers stating that their dozing moments in active 
wake period,  due to inadequate sleep. 
 Trend of melatonin secretion in dim light for shift workers were 
lower when compared to day worker indicating their misalignment 
of hormone for shift worker. 
Further studies may be necessary to define accurate circadian phase 
of shift worker by assessing 24 hour melatonin and also influence of other 
hormones on melatonin. In future association of memory, cognition and 
prospective well being can also be studied for shift worker for obtaining 
mechanisms underlying pathophysiology of the ill effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
LIMITATION OF THE STUDY 
 24 hour serial assay of melatonin level was not performed, so our 
study could have missed the possible raise of trend of melatonin in 
shift workers in their day time sleep. 
 Only 15 individuals from each group were taken for salivary 
sample collection considering the cost of the ELISA kit. 
 Sleeping environment and socio economic profile for shift workers 
are not same for everyone. Social, personal, domestic factors may 
influence their quality of sleep further then their work. 
 Sleep quality was assessed subjectively which could not exclude 
personal scoring bias. 
 
 
 
 
 
 
 
 
 
SUMMARY 
SUMMARY 
 Globalization leads round the clock service providers (shift 
workers) vulnerable for circadian rhythm sleep disorders. It should be 
considered in the differential diagnosis of patients presenting with 
symptoms of insomnia or excessive sleepiness. Delayed sleep phase type 
and advanced sleep phase type circadian rhythm sleep disorders may be 
associated with other types of sleep disorders, creating the diagnosis and 
treatment even more difficult for health care provider. For successful 
management of circadian rhythm sleep disorders, one must obtain as 
accurate measure of circadian timing as possible. Sleep onset time 
(determined by sleep diary or actigraphy) can be useful to determine 
circadian phase (dim light melatonin onset occurs approximately 2 hours 
after sleep onset) in the clinical setting. 
 Health education, awareness of sleep physiology, behavioral 
interventions such as sleep hygiene, enforcement of stable sleep and wake 
times, prevention of exposure for light at the wrong time of the day and 
exposure to light at the correct time of day are the basic approach for all 
the patients. For the treatment of DSPT and nonentrained type, 
administration of melatonin may be useful. However, use of melatonin 
for the treatment of circadian rhythm sleep disorders has not been 
approved by the U.S Food and Drug Administration, and vascular and 
endocrine adverse effects need to be taken into account, particularly in 
patients who are at increased risk. 
           Bright light and melatonin can be used successfully in the 
treatment of circadian rhythm sleep disorders. However, appropriate 
timing of the treatment is crucial for the effect. An estimation of the 
Patient's circadian phase is therefore important before the treatment is 
started. In clinical practice, a careful patient history may give sufficient 
information in order to estimate the circadian phase. Appropriate timing 
of melatonin administration is about 12hour after bright light treatment. 
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ANNEXURES 
  
  
INFORMED CONSENT FORM 
Title of the study:  “Study of pattern of secretion of Melatonin in 
saliva and sleep parameters in shift workers as compared to day 
workers” 
Name of the Participant:  
Name of the Principal Investigator: Dr.N.S.Sasikumar 
Name of the Institution:  
Institute of Physiology and Experimental Medicine, 
          Madras Medical College and Govt. General Hospital, 
          Chennai - 3 
Documentation of the informed consent 
I _____________________________ have read the information in 
this form (or it has been read to me). I was free to ask any questions and 
they have been answered. I am over 18 years of age and, exercising my 
free power of choice, hereby give my consent to be included as a 
participant in 
“Study of pattern of secretion of Melatonin in saliva and sleep 
parameters in shift workers as compared to day workers” 
1. I have read and understood this consent form and the 
information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by 
the investigator. 
5. I have been informed the investigator of all the treatments I am 
taking or have taken in the past ________ months including 
any native (alternative) treatment. 
6. I have been advised about the risks associated with my 
participation in this study. 
7. I agree to cooperate with the investigator and I will inform 
him/her immediately if I suffer unusual symptoms.  
8. I have not participated in any research study within the past 
_________month(s).  
9. I am aware of the fact that I can opt out of the study at any time 
without having to give any reason and this will not affect my 
future treatment in this hospital.  
10. I am also aware that the investigator may terminate my 
participation in the study at any time, for any reason, without 
my consent.  
11. I hereby give permission to the investigators to release the 
information obtained from me as result of participation in this 
study to the sponsors, regulatory authorities, Govt. agencies, 
and IEC. I understand that they are publicly presented. 
12. I have understood that my identity will be kept confidential if 
my data are publicly presented. 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact 
the investigator. By signing this consent form I attest that the information 
given in this document has been clearly explained to me and understood 
by me, I will be given a copy of this consent document. 
  
For adult participants: 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
 
Name _________________________ Signature_________________  
 
Date________________ 
 
Name and Signature of impartial witness (required for illiterate 
patients): 
 
Name _________________________ Signature_________________  
 
Date________________ 
 
Address and contact number of the impartial witness: 
 
Name and Signature of the investigator or his representative 
obtaining consent: 
 
Name _________________________ Signature_________________  
 
Date________________ 
 
  
PROFORMA 
1. Name : 
2. Age: 
3. Sex: 
4. Address : 
5. Occupation : 
6. Complaints/duration: 
7.  History of present illness: 
8. History of any hearing problem after the onset of epilepsy? 
9. Past history: 
10. History of any drug intake 
11. History of associated illness: 
a. Diabetes 
b. Hypertension 
c. Ischemic heart disease 
d. Respiratory diseases 
e. Renal diseases 
Investigations: 
Salivary melatonin levels 
EXAMINATION 
 
General examination: 
Temperature:   Pulse rate    Blood pressure:  
 
Systemic examination: 
Cardiovascular system: 
Respiratory system: 
Gastrointestinal system: 
Central nervous system: 
  
  
PROFORMA 
1. Name : 
2. Age: 
3. Sex: 
4. Address : 
5. Occupation : 
6. Complaints/duration: 
7.  History of present illness: 
8. History of any hearing problem after the onset of epilepsy? 
9. Past history: 
10. History of any drug intake 
11. History of associated illness: 
a. Diabetes 
b. Hypertension 
c. Ischemic heart disease 
d. Respiratory diseases 
e. Renal diseases 
Investigations: 
Salivary melatonin levels 
EXAMINATION 
 
General examination: 
Temperature:   Pulse rate    Blood pressure:  
 
Systemic examination: 
Cardiovascular system: 
Respiratory system: 
Gastrointestinal system: 
Central nervous system: 
 
S No age BMI stage I stage II stage III stage IV REM stage I% stage II% stage III% stage IV%
Rapid Eye 
Mov.%
TST
NAP 
time
NAP 
status
NAP onset 
latency
PSQI ESS
8:00 PM 10:00 PM 12:00 AM
1 21 20.24 25 191 54 46 81.5 6.29% 48.05% 13.58% 11.57% 20.50% 397.5 397.5 91.27 5 0 13 3.5 4.8 6.6
2 21 22.95 19.5 201.5 40 48 82.5 4.98% 51.47% 10.22% 12.26% 21.07% 391.5 391.5 92.23 12.5 0 3 3.8 5.5 7.1
3 22 23.53 34 220 40 32 71 8.56% 55.42% 10.08% 8.06% 17.88% 397 397 89.92 14 1 7 3.7 5.8 6.9
4 21 23.60 31.5 195 40 52 74.5 8.02% 49.62% 10.18% 13.23% 18.96% 393 393 75.6 18 1 4 3.6 5.7 6.7
5 21 21.30 29 221 30 35 67 7.59% 57.85% 7.85% 9.16% 17.54% 382 382 88.02 16.5 5 8 4 5.6 7
6 22 20.66 13.5 191 39 43 91 3.58% 50.60% 10.33% 11.39% 24.11% 377.5 377.5 92.52 7.5 5 7 3.9 5.9 6.8
7 21 20.76 18 195 44 56 85 4.52% 48.99% 11.06% 14.07% 21.36% 398 398 89.54 14 0 6 3.8 6 6.7
8 22 22.68 12.5 184 46 44.5 93.5 3.29% 48.36% 12.09% 11.70% 24.57% 380.5 380.5 90.38 6 0 6 4.2 5.5 6.8
9 21 21.71 28 180 43.5 46 64.5 7.73% 49.72% 12.02% 12.71% 17.82% 362 362 95.89 14 0 8 3.6 5.8 6.9
10 22 25.28 18 202.5 37.5 34.5 68.5 4.99% 56.09% 10.39% 9.56% 18.98% 361 361 95.76 7 0 8 3.8 5.6 7.1
11 21 22.95 21.5 216.5 32 29.5 63 5.93% 59.72% 8.83% 8.14% 17.38% 362.5 362.5 94.03 6.5 2 8 4.6 5.7 6.6
12 21 22.48 28 223.5 42 32.5 79 6.91% 55.19% 10.37% 8.02% 19.51% 405 405 90 8.5 0 7 3.7 6 6.7
13 21 25.97 19 213 40 49 70.5 4.85% 54.41% 10.22% 12.52% 18.01% 391.5 391.5 91.15 17.5 2 4 4.7 6.2 6.8
14 22 24.51 11.5 202 42.5 39 70.5 3.15% 55.27% 11.63% 10.67% 19.29% 365.5 365.5 93.24 18 0 6 4.8 5.9 6.9
15 21 25.10 15.5 198.5 31 37 102 4.04% 51.69% 8.07% 9.64% 26.56% 384 384 91.43 14 2 4 3.8 6.1 7.2
16 21 22.68 26 201 41.5 43 88.5 6.50% 50.25% 10.38% 10.75% 22.13% 400 400 93.35 15 0 5
17 22 23.59 16 172 43 39 91 4.43% 47.65% 11.91% 10.80% 25.21% 361 361 94.63 15.5 0 3
18 22 22.04 25.5 203 28 34 87 6.75% 53.77% 7.42% 9.01% 23.05% 377.5 377.5 91.29 9.5 0 4
19 21 21.80 19 182 48 61 91 4.74% 45.39% 11.97% 15.21% 22.69% 401 401 91.66 7.5 0 9
20 21 23.53 14.5 216.5 38 26 90.5 3.76% 56.16% 9.86% 6.74% 23.48% 385.5 385.5 95.54 10 0 6
21 22 23.60 19 202 31 43 70.5 5.20% 55.27% 8.48% 11.76% 19.29% 365.5 365.5 90.25 16.5 0 4
22 21 20.62 16.5 219 40.5 39 77.5 4.20% 55.80% 10.32% 9.94% 19.75% 392.5 392.5 92.57 12 1 8
23 21 22.06 22 212 36 32 75 5.84% 56.23% 9.55% 8.49% 19.89% 377 377 93.66 18 0 5
24 21 24.02 17 210 33 41 68 4.61% 56.91% 8.94% 11.11% 18.43% 369 369 95.6 22 1 8
25 22 24.39 19.5 232 38 48 79 4.68% 55.70% 9.12% 11.52% 18.97% 416.5 416.5 88.52 22.5 0 6
26 21 25.97 24.5 199 49 50.5 82 6.05% 49.14% 12.10% 12.47% 20.25% 405 405 90.5 17 0 4
27 22 23.51 20 224 37 42.5 91.5 4.82% 53.98% 8.92% 10.24% 22.05% 415 415 92.53 13.5 0 6
28 21 21.61 21 218 34 49 86.5 5.14% 53.37% 8.32% 12.00% 21.18% 408.5 408.5 89.49 17 1 4
29 21 21.16 22 200 36 48 90 5.56% 50.51% 9.09% 12.12% 22.73% 396 396 93.95 10.5 1 9
30 21 20.07 20 185 44 40 82 5.39% 49.87% 11.86% 10.78% 22.10% 371 371 91.04 12 1 7
melatonin level
MASTER CHART- DAY WORKER
S No age BMI stage I stage II stage III stage IV REM stage I% stage II% stage III% stage IV% Rapid Eye Mov.% TST NAP time
NAP 
status
NAP onset 
latency PSQI ESS
8:00 PM 10:00 PM 12:00 AM
1 28 23.46 24 204 15 20.5 45 7.78% 66.13% 4.86% 6.65% 14.59% 308.5 308.5 67.95 9 1 2 3.5 5 5.7
2 29 23.80 20.5 205.5 38 46 62.5 5.50% 55.17% 10.20% 12.35% 16.78% 372.5 372.5 80.54 18 3 5 2.9 4.8 6.1
3 22 24.74 36 222 38 30 43 9.76% 60.16% 10.30% 8.13% 11.65% 369 369 89.89 19 7 11 3 3.8 5.8
4 25 24.39 32.5 198 38 49 52 8.80% 53.59% 10.28% 13.26% 14.07% 369.5 369.5 74.57 22 3 13 3.1 4.2 5.6
5 23 22.96 30.5 224 28.5 33 57 8.18% 60.05% 7.64% 8.85% 15.28% 373 373 91.31 18 4 1 3.2 4.4 5.9
6 24 24.16 15.5 194 37 40 69 4.36% 54.57% 10.41% 11.25% 19.41% 355.5 355.5 89.21 17.5 6 1 4 5.8 5.7
7 25 20.80 21 197 41 54 75 5.41% 50.77% 10.57% 13.92% 19.33% 388 388 86.9 19 2 11 3.8 5.7 6.2
8 29 24.09 14.5 188 43 42 81.5 3.93% 50.95% 11.65% 11.38% 22.09% 369 369 82.37 20 4 4 4.2 5.5 5.9
9 28 25.40 30 183 41 44 53.5 8.53% 52.06% 11.66% 12.52% 15.22% 351.5 351.5 84.6 22 4 12 3.8 4.3 6
10 21 24.96 19.5 205.5 35 31 57.5 5.60% 58.97% 10.04% 8.90% 16.50% 348.5 348.5 92.07 19.5 7 6 4 4.5 5.2
11 23 26.29 23.5 220 29 26.5 52 6.70% 62.68% 8.26% 7.55% 14.81% 351 351 89.88 16.5 4 10 3.9 4.8 5.8
12 21 24.91 30 227 39 29 54.5 7.91% 59.82% 10.28% 7.64% 14.36% 379.5 379.5 85.96 20.5 2 12 4.8 5.2 5.7
13 23 24.01 21 215 38 46 52.5 5.64% 57.72% 10.20% 12.35% 14.09% 372.5 372.5 86.73 18.5 3 10 3.8 4.1 5.8
14 27 22.86 13.5 205 39.5 36 59.5 3.82% 57.99% 11.17% 10.18% 16.83% 353.5 353.5 90.06 22 13 9 4.7 5.4 6.1
15 26 24.39 17.5 201.5 28 34 78 4.87% 56.13% 7.80% 9.47% 21.73% 359 359 88.97 23 4 12 3.9 5.8 6
16 23 24.39 28 204 38.5 40 77.5 7.22% 52.58% 9.92% 10.31% 19.97% 388 388 72.73 19.5 3 11
17 23 25.97 19 175 40.5 36 76 5.48% 50.51% 11.69% 10.39% 21.93% 346.5 346.5 89.65 18.5 2 11
18 26 24.98 28 206 26 31 76 7.63% 56.13% 7.08% 8.45% 20.71% 367 367 80.57 19 8 9
19 30 24.51 21 186 45 57 80 5.40% 47.81% 11.57% 14.65% 20.57% 389 389 75.61 17 6 9
20 30 27.05 17.5 188 35 24 71.5 5.21% 55.95% 10.42% 7.14% 21.28% 336 336 67.6 19.5 3 15
21 25 26.03 21.5 205 29 40 59 6.06% 57.83% 8.18% 11.28% 16.64% 354.5 354.5 86.67 21.5 1 11
22 23 22.41 19 223 38.5 35 47 5.24% 61.52% 10.62% 9.66% 12.97% 362.5 362.5 87.77 21.5 4 10
23 24 23.51 24 215.5 33.5 30 64 6.54% 58.72% 9.13% 8.17% 17.44% 367 367 84.66 22.5 4 7
24 26 22.48 19.5 214 30 38.5 57 5.43% 59.61% 8.36% 10.72% 15.88% 359 359 88.86 23.5 2 10
25 24 24.74 21.5 235 35.5 45 64 5.36% 58.60% 8.85% 11.22% 15.96% 401 401 79.88 28.5 8 12
26 24 21.83 22.5 180 42 41.5 58 6.54% 52.33% 12.21% 12.06% 16.86% 344 344 67.92 23 3 12
27 23 21.94 21.5 226.5 35 38.5 80.5 5.35% 56.34% 8.71% 9.58% 20.02% 402 402 85.81 20 4 13
28 23 21.99 26 222 32 45.5 75.5 6.48% 55.36% 7.98% 11.35% 18.83% 401 401 92.18 18.5 2 7
29 24 21.08 23.5 210 32.5 44.5 74 6.11% 54.62% 8.45% 11.57% 19.25% 384.5 384.5 88.7 16 2 2
30 27 27.01 21 190 41 36.5 68.5 5.88% 53.22% 11.48% 10.22% 19.19% 357 357 84.7 19 1 2
melatonin level
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